<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ALRT="http://alrt.com/20211231"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="alrt-20211231.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-03-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2022-03-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_ObligationToIssueSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ALRT:ObligationToIssueSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ObligationToIssueSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ALRT:ObligationToIssueSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ObligationToIssueSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ALRT:ObligationToIssueSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ObligationToIssueSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ALRT:ObligationToIssueSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ObligationToIssueSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ALRT:ObligationToIssueSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options14Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options14Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options15Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options15Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options18Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options18Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options19Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options19Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options22Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options22Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options23Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options23Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options24Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options24Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options24Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options24Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options25Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options25Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options26Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options26Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options26Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options26Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options27Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options27Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options27Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options27Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options28Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options28Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_Options28Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options28Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TaxYear2002Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">ALRT:TaxYear2002Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TaxYear2003Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">ALRT:TaxYear2003Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TaxYear2004Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">ALRT:TaxYear2004Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TaxYear2005Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">ALRT:TaxYear2005Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2006Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2007Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2007Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2008Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2008Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2009Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2009Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2010Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2011Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2011Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2012Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2013Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2013Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2014Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2014Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2015Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2016Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2017Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2018Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2019Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2020Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TaxYear2021Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-12-31">0001087022</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-12-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-12-31">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0029">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0030">Yes</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0031">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0032">No</dei:EntityInteractiveDataCurrent>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0100"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0102"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ObligationToIssueShares
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0125"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0132"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0144"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0147"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0150"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:LossOnSettlementOfDebt
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0177"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0179"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0192"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0204"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0206"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2020-01-012020-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0213"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0215"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0216"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0222"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0224"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0225"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ShareSubscriptionsCollected
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0230"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ShareSubscriptionsCollected
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0232"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ShareSubscriptionsCollected
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0233"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ShareSubscriptionsCollected
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0234"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ImputedInterest
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0237"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ImputedInterest
      contextRef="From2020-01-012020-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0238"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ImputedInterest
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0240"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ImputedInterest
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0241"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0244"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0245"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0247"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0248"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0251"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0252"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0253"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0254"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0261"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2021-01-012021-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0269"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0278"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0279"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:CancelledShares
      contextRef="From2021-01-012021-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0285"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:CancelledShares
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0287"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:CancelledShares
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0288"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:CancelledShares
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0289"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ImputedInterest
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0293"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ImputedInterest
      contextRef="From2021-01-012021-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0294"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ImputedInterest
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ImputedInterest
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0297"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0300"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0304"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-01-012021-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0308"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0315"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0316"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_ObligationToIssueSharesMember"
      id="xdx2ixbrl0322"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:StockbasedCompensationinterest
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:SharesIssuedForServices
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:WriteoffOfAccountsPayable
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:RepaymentOfLinesOfCreditInterest
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ProceedsFromShareSubscriptionsReceived
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0787"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0789"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options1Member"
      id="xdx2ixbrl0866"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options5Member"
      id="xdx2ixbrl0914"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options6Member"
      id="xdx2ixbrl0926"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options15Member"
      id="xdx2ixbrl1034"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options18Member"
      id="xdx2ixbrl1070"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options25Member"
      id="xdx2ixbrl1160"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options25Member"
      id="xdx2ixbrl1162"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options25Member"
      id="xdx2ixbrl1164"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options26Member"
      id="xdx2ixbrl1172"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options26Member"
      id="xdx2ixbrl1174"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options26Member"
      id="xdx2ixbrl1176"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options27Member"
      id="xdx2ixbrl1184"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options27Member"
      id="xdx2ixbrl1186"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options27Member"
      id="xdx2ixbrl1188"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options28Member"
      id="xdx2ixbrl1196"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options28Member"
      id="xdx2ixbrl1198"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options28Member"
      id="xdx2ixbrl1200"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseOther
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1231"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1291"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:InterestExpenseRelatedToStockOptionsGrantedToSpouseOfChairmanAndChiefExecutiveOfficerOfCompanyRelatedToIncreaseOfBorrowingLimitOfLineOfCredit
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1294"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1303"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1306"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:StockOptionsGrantedToMemberOfBoardOfDirectorsOfCompany
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1309"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1312"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl1371"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1372"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl1393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1395"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_custom_OtherMember"
      id="xdx2ixbrl1475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_custom_OtherMember"
      id="xdx2ixbrl1477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_country_SG"
      id="xdx2ixbrl1481"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_country_US"
      id="xdx2ixbrl1483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31_country_US"
      id="xdx2ixbrl1485"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1489"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_custom_OtherMember"
      id="xdx2ixbrl1493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_country_SG"
      id="xdx2ixbrl1497"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:CommonStockIssuedToRetirePromissoryNotesPayable
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1518"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:CommonStockIssuedToRetireLineOfCreditPayable
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl1520"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-01-01to2021-12-31">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2021-01-01to2021-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-12-31">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2021-01-01to2021-12-31">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2021-01-01to2021-12-31">000-30414</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-12-31">ALR TECHNOLOGIES INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-12-31">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-12-31">88-0225807</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-12-31">7400 Beaufont Springs Dr</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-01-01to2021-12-31">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-12-31">Richmond</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-01to2021-12-31">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-12-31">23225</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-12-31">(804)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-12-31">554-3500</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">32562981</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-03-30" decimals="INF" unitRef="Shares">542716344</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName contextRef="From2021-01-01to2021-12-31">DALE MATHESON CARR-HILTON LABONTE LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2021-01-01to2021-12-31">Vancouver, Canada</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2021-01-01to2021-12-31">1173</dei:AuditorFirmId>
    <us-gaap:Cash contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">115922</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">66190</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">77295</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">62659</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">193217</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">128849</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1130546</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1113720</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ALRT:PromissoryNotesPayableToRelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3041966</ALRT:PromissoryNotesPayableToRelatedParties>
    <ALRT:PromissoryNotesPayableToRelatedParties contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3031966</ALRT:PromissoryNotesPayableToRelatedParties>
    <ALRT:PromissoryNotesPayableUnrelatedLender contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2213368</ALRT:PromissoryNotesPayableUnrelatedLender>
    <ALRT:PromissoryNotesPayableUnrelatedLender contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2254353</ALRT:PromissoryNotesPayableUnrelatedLender>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4110647</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3575326</us-gaap:InterestPayableCurrent>
    <ALRT:LinesOfCreditFromRelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14008833</ALRT:LinesOfCreditFromRelatedParties>
    <ALRT:LinesOfCreditFromRelatedParties contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11914092</ALRT:LinesOfCreditFromRelatedParties>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24505360</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">21889457</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">500000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">500000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">542716344</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">542716344</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">511020709</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">511020709</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">542716</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">511020</us-gaap:CommonStockValue>
    <ALRT:ObligationToIssueShares contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">200000</ALRT:ObligationToIssueShares>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">77171627</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">71100134</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-11409</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-102015077</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-93571762</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-24312143</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-21760608</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">193217</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">128849</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">7468</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">2523</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">4945</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">498996</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1433027</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">881016</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">953350</us-gaap:ProfessionalFees>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1566306</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1439634</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2946318</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-3826011</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-2941373</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-3826011</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:InterestExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">5468328</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2116466</us-gaap:InterestExpense>
    <ALRT:LossOnSettlementOfDebt
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">33614</ALRT:LossOnSettlementOfDebt>
    <us-gaap:OtherIncome
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">26460</us-gaap:OtherIncome>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-5501942</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-2090006</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-8443315</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-5916017</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-11409</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-8454724</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-5916017</us-gaap:ComprehensiveIncomeNetOfTax>
    <ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">534980347</ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted>
    <ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">337033584</ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted>
    <ALRT:LossPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">-0.02</ALRT:LossPerShareBasicAndDiluted>
    <ALRT:LossPerShareBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">-0.02</ALRT:LossPerShareBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">268777909</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">268777</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">56298702</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-87655745</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-31088266</us-gaap:StockholdersEquity>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebtInShares
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">242000000</ALRT:IssuanceOfCommonStockForSettlementOfDebtInShares>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">242000</ALRT:IssuanceOfCommonStockForSettlementOfDebt>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">11838000</ALRT:IssuanceOfCommonStockForSettlementOfDebt>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">12080000</ALRT:IssuanceOfCommonStockForSettlementOfDebt>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">242800</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">243</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">11897</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">12140</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ALRT:ShareSubscriptionsCollected
      contextRef="From2020-01-012020-12-31_custom_ObligationToIssueSharesMember"
      decimals="0"
      unitRef="USD">200000</ALRT:ShareSubscriptionsCollected>
    <ALRT:ShareSubscriptionsCollected
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">200000</ALRT:ShareSubscriptionsCollected>
    <ALRT:ImputedInterest
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">123518</ALRT:ImputedInterest>
    <ALRT:ImputedInterest
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">123518</ALRT:ImputedInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">2828017</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2828017</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-5916017</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-5916017</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">511020709</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">511020</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_ObligationToIssueSharesMember"
      decimals="0"
      unitRef="USD">200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">71100134</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-93571762</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-21760608</us-gaap:StockholdersEquity>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebtInShares
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">4400000</ALRT:IssuanceOfCommonStockForSettlementOfDebtInShares>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">4400</ALRT:IssuanceOfCommonStockForSettlementOfDebt>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">246400</ALRT:IssuanceOfCommonStockForSettlementOfDebt>
    <ALRT:IssuanceOfCommonStockForSettlementOfDebt
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">250800</ALRT:IssuanceOfCommonStockForSettlementOfDebt>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">27296635</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">27297</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31_custom_ObligationToIssueSharesMember"
      decimals="0"
      unitRef="USD">-200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1309535</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1136832</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <ALRT:CancelledSharesInShares
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-1000</ALRT:CancelledSharesInShares>
    <ALRT:CancelledShares
      contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">-1</ALRT:CancelledShares>
    <ALRT:CancelledShares
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1</ALRT:CancelledShares>
    <ALRT:ImputedInterest
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">112339</ALRT:ImputedInterest>
    <ALRT:ImputedInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">112339</ALRT:ImputedInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">4403218</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">4403218</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-11409</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-11409</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-8443315</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-8443315</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">542716344</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">542716</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">77171627</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">-11409</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-102015077</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-24312143</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-8443315</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-5916017</us-gaap:ProfitLoss>
    <ALRT:StockbasedCompensationproductDevelopmentCosts
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-222178</ALRT:StockbasedCompensationproductDevelopmentCosts>
    <ALRT:StockbasedCompensationproductDevelopmentCosts
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-1156195</ALRT:StockbasedCompensationproductDevelopmentCosts>
    <ALRT:StockbasedCompensationgeneralSellingAndAdministration
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">586538</ALRT:StockbasedCompensationgeneralSellingAndAdministration>
    <ALRT:StockbasedCompensationgeneralSellingAndAdministration
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">930258</ALRT:StockbasedCompensationgeneralSellingAndAdministration>
    <ALRT:StockbasedCompensationProfessionalFees
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">169382</ALRT:StockbasedCompensationProfessionalFees>
    <ALRT:StockbasedCompensationProfessionalFees
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">741564</ALRT:StockbasedCompensationProfessionalFees>
    <ALRT:StockbasedCompensationinterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">3425120</ALRT:StockbasedCompensationinterest>
    <ALRT:InterestExpenseOnLinesOfCredit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1402187</ALRT:InterestExpenseOnLinesOfCredit>
    <ALRT:InterestExpenseOnLinesOfCredit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1464077</ALRT:InterestExpenseOnLinesOfCredit>
    <ALRT:NoncashImputedInterestExpenses
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">112339</ALRT:NoncashImputedInterestExpenses>
    <ALRT:NoncashImputedInterestExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">123518</ALRT:NoncashImputedInterestExpenses>
    <ALRT:SharesIssuedForServices
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-20000</ALRT:SharesIssuedForServices>
    <ALRT:WriteoffOfAccountsPayable
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">26460</ALRT:WriteoffOfAccountsPayable>
    <us-gaap:NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-33614</us-gaap:NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">14636</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">62659</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">211012</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">72099</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">527336</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">528871</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-1768245</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-968554</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1149279</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">820766</us-gaap:ProceedsFromLinesOfCredit>
    <ALRT:RepaymentOfLinesOfCreditInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">456725</ALRT:RepaymentOfLinesOfCreditInterest>
    <ALRT:ProceedsFromShareSubscriptionsReceived
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">200000</ALRT:ProceedsFromShareSubscriptionsReceived>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1136832</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">12140</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1829386</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1032906</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-11409</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">49732</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">64352</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">66190</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1838</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">115922</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">66190</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zdv4xCs8ep87" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_822_zwA2O4d74bT7"&gt;Basis
of presentation, nature of operations and going concern&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;ALR Technologies Inc. (the &#x201c;Company&#x201d;)
was incorporated under the laws of the state of Nevada on March&#160;24, 1987. On May&#160;16, 2020, the Company incorporated a wholly
owned subsidiary, ALR Technologies Sg Pte. Ltd. (&#x201c;ALRT SG&#x201d;), under the &lt;i&gt;Companies Act&lt;/i&gt; of Singapore. On June&#160;9,
2021, the Company incorporated a wholly owned subsidiary, Canada Diabetes Solution Centre, Inc., under the &lt;i&gt;Business Corporations Act
&lt;/i&gt;of Alberta. The Company has developed its Diabetes Solution, which is a comprehensive approach to diabetes care consisting of data
collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring and diabetes test supplies.
The Company is seeking commercial opportunities to deploy the Diabetes Solution in the United States (&#x201c;U.S.&#x201d;), Canada and
Singapore.&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements have been prepared in accordance with U.S. GAAP in U.S. dollars and on a going concern basis, which
presumes the realization of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable
future. Several adverse conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses
over the past several fiscal years (2021&#160;- $&lt;span id="xdx_908_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210101__20211231_zXsbPBz6yJu1" title="Net loss"&gt;8,443,315&lt;/span&gt;; 2020&#160;- $&lt;span id="xdx_907_eus-gaap--ProfitLoss_iN_pp0p0_di_c20200101__20201231_z6MWYJd9ibIi" title="Net loss"&gt;5,916,017&lt;/span&gt;), is currently unable to self-finance its operations,
has a working capital deficit of $&lt;span id="xdx_905_ecustom--WorkingCapitalDeficit_c20211231_pp0p0" title="Working capital deficit"&gt;24,312,143&lt;/span&gt; (2020&#160;- $&lt;span id="xdx_904_ecustom--WorkingCapitalDeficit_c20201231_pp0p0" title="Working capital deficit"&gt;21,760,608&lt;/span&gt;), accumulated deficit of $&lt;span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211231_z8MCXDq3aTnf" title="Accumulated deficit"&gt;102,015,077&lt;/span&gt; (2020&#160;- $&lt;span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20201231_za9L1d8ZlVD2" title="Accumulated deficit"&gt;93,571,762&lt;/span&gt;),
limited resources, no source of operating cash flow and no assurance that sufficient funding will be available to conduct continued product
development activities. If the Company is able to finance its required product development activities, there is no assurance the Company&#x2019;s
current projects will be commercially viable or profitable. The Company has debts comprised of accounts payable and accrued liabilities,
interest payable, lines of credit and promissory notes payable totaling $&lt;span id="xdx_903_eus-gaap--Liabilities_c20211231_pp0p0" title="Liabilities"&gt;24,505,360&lt;/span&gt; (2020&#160;- $&lt;span id="xdx_900_eus-gaap--Liabilities_c20201231_pp0p0" title="Liabilities"&gt;21,889,457&lt;/span&gt;) currently due, due on demand
or considered delinquent. There is no assurance that the Company will not face additional legal action from creditors regarding delinquent
accounts payable, promissory notes payable and interest payable. Any one or a combination of the above conditions could result in the
failure of the business and cause the Company to cease operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s
ability to continue as a going concern is dependent upon the continued financial support of its creditors and its ability to obtain financing
to fund working capital and overhead requirements, fund the development of the Company&#x2019;s product line, and ultimately, the Company&#x2019;s
ability to achieve profitable operations and repay overdue obligations. Management has obtained a mix of equity and line of credit financing
from related parties. The line of credit facilities have available borrowing in principal up to $14,300,000. As of December&#160;31,
2021, the total principal balance outstanding was $12,688,405. The resolution of whether the Company is able to continue as a going concern
is dependent upon the realization of management&#x2019;s plans. There can be no assurance that the Company will be able to raise any additional
debt or equity capital from the sources described above or that the lenders in the line of credit arrangements will maintain the availability
of borrowing from the lines. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations,
the Company will be required to cease operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In March
2020, the World Health Organization declared coronavirus, COVID-19, a global pandemic. This contagious disease outbreak, which has continued
to spread, and any related adverse public health developments, has adversely affected workforces, economies and financial markets globally,
potentially leading to an economic downturn. Management does not expect that COVID-19 will have a significant impact on the Company;
however, it could have a potential impact on the Company&#x2019;s ability to raise money, market its products to attract customers or
procure equipment and parts for its glucose monitoring system.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All of
the Company&#x2019;s debt is either due on demand or is in default, while continuing to accrue interest at its stated rate. The Company
will seek to obtain creditors&#x2019; consents to delay repayment of the outstanding promissory notes payable and related interest thereto,
until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity
financings through private placements. While some of the Company&#x2019;s creditors have agreed to extend repayment deadlines in the past,
there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action
against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to
cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future.
If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to
cease operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s
activities will necessitate significant uses of working capital beyond 2022. Additionally, the Company&#x2019;s capital requirements will
depend on many factors, including the success of the Company&#x2019;s continued product development and distribution efforts. The Company
plans to continue financing its operations with the lines of credit it has available and other sources of financing. On January&#160;18,
2022, the Company filed a prospectus whereby it distributed subscription rights to its shareholders (note&#160;14(a)).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-8443315</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-5916017</us-gaap:ProfitLoss>
    <ALRT:WorkingCapitalDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24312143</ALRT:WorkingCapitalDeficit>
    <ALRT:WorkingCapitalDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">21760608</ALRT:WorkingCapitalDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-102015077</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-93571762</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24505360</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">21889457</us-gaap:Liabilities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zdj11CtkqTXc" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_828_zpluZSvRVt5l"&gt;Significant
accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_z7HQVUBula8l" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 17.45pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_863_zm4tsKuWIhX1"&gt;Basis
                                            of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, ALRT SG, which was incorporated
on May&#160;16, 2020 in Singapore, and Canada Diabetes Solution Centre, Inc., which was incorporated on June&#160;9, 2021 in Alberta,
Canada. The Canadian subsidiary is currently inactive. All significant intercompany balances and transactions have been eliminated on
consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zGkKschmeqi" style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 17.45pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_866_zjVj4J5NCNOk"&gt;Stock-based
                                            compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
follows the fair value method of accounting for stock-based compensation. The Company estimates the fair value of share-based payment
awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest
is recognized as an expense over the requisite service period in the Company&#x2019;s consolidated financial statements. The Company estimates
the fair value of the stock options using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the
input of highly subjective assumptions, including the option&#x2019;s expected life and the price volatility of the underlying stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zC0rOla9LK23" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_869_zkRVN6swBZRc"&gt;Revenue
                                            recognition&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s
primary source of revenue is from subscription fees. Customers are billed in advance of the start of their subscription and revenue is
recognized ratably over each monthly subscription period. The Company is the principal in all its relationships where partners provide
monitoring services as well as testing supplies, as the Company retains control over service delivery to its customers. Payments made
to the partners, such as for marketing, where the price that the customer pays is established by the partners and is part of the subscription,
are recognized as reduction of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--ForeignCurrencyTranslationPolicyTextBlock_zPJbWzZ4YC9g" style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zX6JNtqFemv2"&gt;Foreign
                                            currency translation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The presentation
currency of the Company is the U.S. dollar.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;The functional currency of each of the parent
company and its subsidiaries is measured using the currency of the primary economic environment in which that entity operates. The functional
currency of ALRT SG is the Singapore dollar, for Canada Diabetes Solution Centre, Inc. it is the Canadian dollar, and for the Company
the functional currency it is the U.S. dollar.&lt;/p&gt;
&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transactions
and balances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
currency transactions are translated into the functional currency using the exchange rates prevailing at the date of the transaction.
Foreign currency monetary items are translated at the year-end exchange rate. Non-monetary items measured at historical cost continue
to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange
rate at the date when fair values were determined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
differences arising on the translation are recognized in profit or loss in the consolidated statement of operations in the year in which
they arise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Parent
and subsidiary companies&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The financial
results and position of foreign operations whose functional currency is different from the presentation currency are translated as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
                                            and liabilities are translated at year-end exchange rates prevailing at that reporting date;
                                            and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
                                            and expenses are translated at monthly average exchange rates during the year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;Exchange differences arising on the translation
of foreign operations are transferred directly to the Company&#x2019;s exchange difference on translating foreign operations in the Consolidated
Statements of Operations, and are reported as a separate component of shareholders&#x2019; equity included in &#x201c;Accumulated Other
Comprehensive Loss&#x201d;. These differences are recognized in profit or loss in the Consolidated Statement of Operations in the year
in which they are disposed.&lt;/p&gt;
&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zFIAGj9m4rT6" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_863_zgCH7WiqrhB8"&gt;Income
                                            taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the differences
between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax basis, and
operating loss carry-forwards that are available to be carried forward to future years for tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those
temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in
tax rates is recognized in income in the period that includes the enactment date. When it is not considered to be more likely than not
that a deferred income tax asset will be realized, a valuation allowance is provided for the excess.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
follows the accounting requirements associated with uncertainty in income taxes using the provisions of Financial Accounting Standards
Board Accounting Standards Codification 740 &lt;i&gt;Income Taxes&lt;/i&gt;. Using that guidance, tax positions initially need to be recognized in
the consolidated financial statements when it is more likely than not the positions will be sustained upon examination by the tax authorities.
It also provides guidance for derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
As of December&#160;31, 2021, the Company has &lt;span id="xdx_901_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20211231_z08lc7b9n7kb" title="Uncertain tax positions"&gt;no&lt;/span&gt; uncertain tax positions that qualify for either recognition or disclosure in the consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--UseOfEstimates_zDEOasK4h1ug" style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18.9pt"/&gt;&lt;td style="width: 16.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zCCtkzurm5T"&gt;Use
                                            of estimates&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The preparation
of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements, the measurement of stock-based compensation, the fair value of financial instruments, and the reported amounts of revenues
and expenses during the reporting period. Management believes the estimates are reasonable; however, actual results could differ from
those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zyrsuvJVPnrb" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;g)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_869_z6OynFd4PJA5"&gt;Loss
                                            per share&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;Basic loss per common share is calculated
by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per common share is calculated
by dividing the net loss by the sum of the weighted average number of common shares outstanding and the dilutive common equivalent shares
outstanding during the year. Common equivalent shares consist of the shares issuable upon exercise of stock options and warrants calculated
using the treasury stock method. Common equivalent shares are not included in the calculation of the weighted average number of shares
outstanding for diluted loss per common share when the effect would be anti-dilutive.&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















&lt;p id="xdx_849_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zvr4eocqsCM9" style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;h)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_z61jzl0opL45"&gt;Comprehensive
                                            income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Comprehensive
income is the overall change in the net assets of the Company for a period, other than changes attributable to transactions with stockholders.
It is made up of net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) consists of net income (loss)
and other gains and losses affecting stockholders' equity that under U.S. GAAP are excluded from net income.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z8ZZSC6DWxPc" style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zVefLYFuU2gf"&gt;Fair
                                            value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s
financial instruments include cash, accounts payable, promissory notes payable, interest payable and lines of credit. The fair values
of these financial instruments approximate their carrying values due to the relatively short periods to maturity. For fair value measurement,
U.S. GAAP establishes a three-tier hierarchy that prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 1
&#x2014; observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 2
&#x2014; includes other inputs that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3
&#x2014; unobservable inputs that are supported by little or no market activity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash is
measured at Level 1 inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmxAVikgaIm1" style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&lt;span id="xdx_867_ziwqnZgx9m0d"&gt;Recently adopted and issued accounting pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Issued&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
has implemented all new accounting pronouncements that are in effect and may impact its consolidated financial statements. The Company
does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its
consolidated financial position or consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_z7HQVUBula8l" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 17.45pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_863_zm4tsKuWIhX1"&gt;Basis
                                            of consolidation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, ALRT SG, which was incorporated
on May&#160;16, 2020 in Singapore, and Canada Diabetes Solution Centre, Inc., which was incorporated on June&#160;9, 2021 in Alberta,
Canada. The Canadian subsidiary is currently inactive. All significant intercompany balances and transactions have been eliminated on
consolidation.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_843_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zGkKschmeqi" style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 17.45pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_866_zjVj4J5NCNOk"&gt;Stock-based
                                            compensation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
follows the fair value method of accounting for stock-based compensation. The Company estimates the fair value of share-based payment
awards on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest
is recognized as an expense over the requisite service period in the Company&#x2019;s consolidated financial statements. The Company estimates
the fair value of the stock options using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the
input of highly subjective assumptions, including the option&#x2019;s expected life and the price volatility of the underlying stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zC0rOla9LK23" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_869_zkRVN6swBZRc"&gt;Revenue
                                            recognition&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s
primary source of revenue is from subscription fees. Customers are billed in advance of the start of their subscription and revenue is
recognized ratably over each monthly subscription period. The Company is the principal in all its relationships where partners provide
monitoring services as well as testing supplies, as the Company retains control over service delivery to its customers. Payments made
to the partners, such as for marketing, where the price that the customer pays is established by the partners and is part of the subscription,
are recognized as reduction of revenue.&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <ALRT:ForeignCurrencyTranslationPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_ecustom--ForeignCurrencyTranslationPolicyTextBlock_zPJbWzZ4YC9g" style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zX6JNtqFemv2"&gt;Foreign
                                            currency translation&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The presentation
currency of the Company is the U.S. dollar.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;The functional currency of each of the parent
company and its subsidiaries is measured using the currency of the primary economic environment in which that entity operates. The functional
currency of ALRT SG is the Singapore dollar, for Canada Diabetes Solution Centre, Inc. it is the Canadian dollar, and for the Company
the functional currency it is the U.S. dollar.&lt;/p&gt;
&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transactions
and balances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
currency transactions are translated into the functional currency using the exchange rates prevailing at the date of the transaction.
Foreign currency monetary items are translated at the year-end exchange rate. Non-monetary items measured at historical cost continue
to be carried at the exchange rate at the date of the transaction. Non-monetary items measured at fair value are reported at the exchange
rate at the date when fair values were determined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
differences arising on the translation are recognized in profit or loss in the consolidated statement of operations in the year in which
they arise.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Parent
and subsidiary companies&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The financial
results and position of foreign operations whose functional currency is different from the presentation currency are translated as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
                                            and liabilities are translated at year-end exchange rates prevailing at that reporting date;
                                            and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
                                            and expenses are translated at monthly average exchange rates during the year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;Exchange differences arising on the translation
of foreign operations are transferred directly to the Company&#x2019;s exchange difference on translating foreign operations in the Consolidated
Statements of Operations, and are reported as a separate component of shareholders&#x2019; equity included in &#x201c;Accumulated Other
Comprehensive Loss&#x201d;. These differences are recognized in profit or loss in the Consolidated Statement of Operations in the year
in which they are disposed.&lt;/p&gt;
&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















</ALRT:ForeignCurrencyTranslationPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zFIAGj9m4rT6" style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_863_zgCH7WiqrhB8"&gt;Income
                                            taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the differences
between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax basis, and
operating loss carry-forwards that are available to be carried forward to future years for tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those
temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in
tax rates is recognized in income in the period that includes the enactment date. When it is not considered to be more likely than not
that a deferred income tax asset will be realized, a valuation allowance is provided for the excess.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
follows the accounting requirements associated with uncertainty in income taxes using the provisions of Financial Accounting Standards
Board Accounting Standards Codification 740 &lt;i&gt;Income Taxes&lt;/i&gt;. Using that guidance, tax positions initially need to be recognized in
the consolidated financial statements when it is more likely than not the positions will be sustained upon examination by the tax authorities.
It also provides guidance for derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
As of December&#160;31, 2021, the Company has &lt;span id="xdx_901_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_do_c20211231_z08lc7b9n7kb" title="Uncertain tax positions"&gt;no&lt;/span&gt; uncertain tax positions that qualify for either recognition or disclosure in the consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LiabilityForUncertainTaxPositionsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:LiabilityForUncertainTaxPositionsCurrent>
    <us-gaap:UseOfEstimates contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_eus-gaap--UseOfEstimates_zDEOasK4h1ug" style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18.9pt"/&gt;&lt;td style="width: 16.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_860_zCCtkzurm5T"&gt;Use
                                            of estimates&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 35.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The preparation
of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial
statements, the measurement of stock-based compensation, the fair value of financial instruments, and the reported amounts of revenues
and expenses during the reporting period. Management believes the estimates are reasonable; however, actual results could differ from
those estimates.&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zyrsuvJVPnrb" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;g)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_869_z6OynFd4PJA5"&gt;Loss
                                            per share&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;Basic loss per common share is calculated
by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per common share is calculated
by dividing the net loss by the sum of the weighted average number of common shares outstanding and the dilutive common equivalent shares
outstanding during the year. Common equivalent shares consist of the shares issuable upon exercise of stock options and warrants calculated
using the treasury stock method. Common equivalent shares are not included in the calculation of the weighted average number of shares
outstanding for diluted loss per common share when the effect would be anti-dilutive.&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_849_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zvr4eocqsCM9" style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;h)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86A_z61jzl0opL45"&gt;Comprehensive
                                            income (loss)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Comprehensive
income is the overall change in the net assets of the Company for a period, other than changes attributable to transactions with stockholders.
It is made up of net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) consists of net income (loss)
and other gains and losses affecting stockholders' equity that under U.S. GAAP are excluded from net income.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_844_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z8ZZSC6DWxPc" style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86E_zVefLYFuU2gf"&gt;Fair
                                            value of financial instruments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s
financial instruments include cash, accounts payable, promissory notes payable, interest payable and lines of credit. The fair values
of these financial instruments approximate their carrying values due to the relatively short periods to maturity. For fair value measurement,
U.S. GAAP establishes a three-tier hierarchy that prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 1
&#x2014; observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 2
&#x2014; includes other inputs that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level 3
&#x2014; unobservable inputs that are supported by little or no market activity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash is
measured at Level 1 inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmxAVikgaIm1" style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&lt;span id="xdx_867_ziwqnZgx9m0d"&gt;Recently adopted and issued accounting pronouncements&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Issued&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
has implemented all new accounting pronouncements that are in effect and may impact its consolidated financial statements. The Company
does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its
consolidated financial position or consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zJNUhxSJCmM6" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_82A_zzAAaIJl42lk"&gt;Accounts
payable and accrued liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A summary of the accounts payable
and accrued liabilities is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z4TnCoTdXool" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B7_zgbTglK8RWlk" style="display: none"&gt;Schedule of accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20211231_zfjjYcyYwit1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20201231_zsP9csjHPsf8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzNXC_zMhIRsdzcSfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; padding-left: 5.4pt"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;806,059&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;874,754&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzNXC_znHiB0EwUA28" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&#160;Accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;322,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;238,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzNXC_zSpslEkUOLT9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0500"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzNXC_zyT66ntG9LVh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,130,546&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,113,720&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z4TnCoTdXool" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B7_zgbTglK8RWlk" style="display: none"&gt;Schedule of accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20211231_zfjjYcyYwit1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20201231_zsP9csjHPsf8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzNXC_zMhIRsdzcSfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; padding-left: 5.4pt"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;806,059&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;874,754&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzNXC_znHiB0EwUA28" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&#160;Accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;322,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;238,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzNXC_zSpslEkUOLT9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0500"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzNXC_zyT66ntG9LVh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,130,546&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,113,720&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">806059</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">874754</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">322087</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">238966</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2400</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1130546</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1113720</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_ecustom--InterestAdvancesAndPromissoryNotesPayableTextBlock_z4R03b3SPU2a" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_827_zMhnXxmPbEF3"&gt;Interest,
advances and promissory notes payable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to related parties&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of activities of promissory notes payable to related parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfPromissorNotesPayableToRelatedPartiesTextBlock_hus-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zqqognmEwON3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8BA_zT1Oizlbswma" style="display: none"&gt;Schedule
    of promissory notes payable to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2019 and 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zqu4V15C52if" style="width: 18%; text-align: right" title="Carrying value at beginning"&gt;3,031,966&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred from promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_z7LEDO4zzSgh" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending"&gt;3,041,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zNQwxCrz9aVh" style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A summary
of the promissory notes payable to related parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_z8utBOtlna6b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;&lt;span id="xdx_8BC_zvL5OAoFidH6" style="display: none"&gt;Schedule of activity of promissory notes payable to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20211231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20201231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzWPK_ziTgbHli3EE6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-indent: -0.25in; padding-left: 0.5in"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;720,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;720,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--InterestAt1.25PerMonth_i01NI_pp0p0_di_msPNRPzWPK_zkGa1LKNfgG8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzWPK_zpHslkzEKaD5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in"&gt;iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzWPK_z3SgT2ftR0gf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;695,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;695,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_iI_pp0p0_maPNRPzWPK_zq6KtEi7Lhf8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,475,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,465,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzWPK_zWKx5fLzmFC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Total Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,041,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,031,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zlIKgrcw9bQ2" style="margin: 0 0 0 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All amounts
past maturity continue to accrue interest at their stated rate and are considered due on demand.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;






















&lt;p style="margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to unrelated parties&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of activities of promissory notes payable to unrelated parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_hus-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zfmVfHR9hWF4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8B8_z8taTbZTu3tg" style="display: none"&gt;Schedule of activities of promissory notes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying &lt;br/&gt;Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2019 and 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NotesPayable_c20201231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="width: 18%; text-align: right" title="Balance at beginning"&gt;2,254,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified to interest payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable"&gt;(10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Extinguished through issuance of shares of common stock (note&#160;6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)"&gt;(20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred to promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;(10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zD7HUig8246i" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;2,213,368&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zvfAiIoMDxLh" style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A summary
of the promissory notes payable to unrelated parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_zpc0UbGvFs87" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;&lt;span id="xdx_8BB_zpz7hl0vq7g" style="display: none"&gt;Schedule of activity of promissory notes payable to unrelated parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20211231_zKPBBWDMim39" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20201231_zc3JoB1i8zL6" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Unsecured promissory notes payable to unrelated lenders, past maturity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTz7Ci_zLtGDltQ3FV9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-indent: -0.25in; padding-left: 0.5in"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,317,456&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,337,456&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTz7Ci_zHo1MNZczqz5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;ii.&#160;&#160;&#160;&#160;&#160; Interest at 0.667% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;425,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;435,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--Vi.InterestAt0.667PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTz7Ci_zYeMkzuBzqC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;iii.&#160;&#160;&#160; Interest at 0.625% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTz7Ci_z7oSKDDrOSSh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in"&gt;iv.&#160;&#160;&#160;&#160; Non-interest-bearing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;270,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;270,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTz7Ci_z1YlDSMjUSSk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;50,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTz7Ci_ztB5hz3Likw4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Total Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,213,368&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,254,353&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zD1wtzSpSshd" style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All amounts
past maturity continue to accrue interest at their stated rate and are considered due on demand.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
payable&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A summary
of interest payable activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--InterestAndOtherIncomeTableTextBlock_zGLsJkFb2iy9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zCPD5Eubohed" style="display: none"&gt;Scheduled of summary of interest payable activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying &lt;br/&gt;Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2019&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20200101__20201231_zSLmk8oOkf3d" style="width: 18%; text-align: right" title="Beginning Balance"&gt;5,364,997&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20200101__20201231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable"&gt;528,871&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest payable retired through issuance of shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20200101__20201231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares"&gt;(2,318,542&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_zr5LrUGdYTk4" style="text-align: right" title="Beginning Balance"&gt;3,575,326&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified from promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ReclassifiedFromPromissoryNotesPayable_iP3us-gaap--InterestPayableCurrentAndNoncurrent_pp0p0_c20210101__20211231_zNsHM9JZqh4k" style="text-align: right" title="Reclassified from promissory notes payable"&gt;10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable"&gt;527,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest payable retired through issuance of shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares"&gt;(3,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20210101__20211231_z6Tsv6Ghb2mc" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"&gt;4,110,647&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zvRT8QGmpsv3" style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
payable is due to related and unrelated parties as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zVPkAZlxnDH5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B0_zV63rWfNbDO3" style="display: none"&gt;Schedule of Interest payable is due to related&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20211231_zF7t41xAvwze" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20201231_zpLUr2i3Rgi4" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Related parties&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,200,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;873,666&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Non-related parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,910,477&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,701,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Interest payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,110,647&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,575,326&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zh5LJSaU4Ld1" style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The payment
terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
expense&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December&#160;31, 2021, the Company incurred interest expense of $&lt;span id="xdx_90E_eus-gaap--InterestExpense_c20210101__20211231_pp0p0" title="Interest expense"&gt;5,468,328&lt;/span&gt; (2020&#160;- $&lt;span id="xdx_90C_eus-gaap--InterestExpense_c20200101__20201231_pp0p0" title="Interest expense"&gt;2,116,466&lt;/span&gt;) as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$3,425,120
                                            (2020&#160;- $nil &lt;span style="display: none"&gt;0&lt;/span&gt;) incurred related to 1) the grant of options as consideration for receiving
                                            an increase to the borrowing limit on the line of credit between the Company and the spouse
                                            of the Chairman (note 7), and 2) the modification of options held by the Chairman and his
                                            spouse that were granted in connection with financing provided to the Company (note 7);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$1,402,187
                                            (2020&#160;- $1,464,077) incurred on lines of credit payable, as shown in note&#160;5; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$527,336
                                            (2020&#160;- $528,871) incurred on promissory notes (notes&#160;4(a) and 4(b));&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$112,339
                                            (2020&#160;- $123,518) incurred from the calculation of imputed interest on accounts payable
                                            outstanding for longer than one year, advances payable and promissory notes payable, which
                                            had no stated interest rate; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$1,346
                                            (2020&#160;- $nil &lt;span style="display: none"&gt;0&lt;/span&gt;) incurred on other items.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock>
    <ALRT:ScheduleOfPromissorNotesPayableToRelatedPartiesTextBlock contextRef="From2021-01-012021-12-31_custom_RelatedPartyMember">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfPromissorNotesPayableToRelatedPartiesTextBlock_hus-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zqqognmEwON3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8BA_zT1Oizlbswma" style="display: none"&gt;Schedule
    of promissory notes payable to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2019 and 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zqu4V15C52if" style="width: 18%; text-align: right" title="Carrying value at beginning"&gt;3,031,966&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred from promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_z7LEDO4zzSgh" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending"&gt;3,041,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:ScheduleOfPromissorNotesPayableToRelatedPartiesTextBlock>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="AsOf2020-12-31_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">3031966</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.
      contextRef="From2021-01-012021-12-31_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">10000</ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="AsOf2021-12-31_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">3041966</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_z8utBOtlna6b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;&lt;span id="xdx_8BC_zvL5OAoFidH6" style="display: none"&gt;Schedule of activity of promissory notes payable to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20211231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20201231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzWPK_ziTgbHli3EE6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-indent: -0.25in; padding-left: 0.5in"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;720,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;720,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--InterestAt1.25PerMonth_i01NI_pp0p0_di_msPNRPzWPK_zkGa1LKNfgG8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzWPK_zpHslkzEKaD5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in"&gt;iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzWPK_z3SgT2ftR0gf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;695,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;695,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_iI_pp0p0_maPNRPzWPK_zq6KtEi7Lhf8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,475,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,465,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzWPK_zWKx5fLzmFC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Total Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,041,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,031,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock>
    <ALRT:NotePayablewithInterestat1PercentInterestperMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">720619</ALRT:NotePayablewithInterestat1PercentInterestperMonth>
    <ALRT:NotePayablewithInterestat1PercentInterestperMonth contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">720619</ALRT:NotePayablewithInterestat1PercentInterestperMonth>
    <ALRT:InterestAt1.25PerMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-51347</ALRT:InterestAt1.25PerMonth>
    <ALRT:InterestAt1.25PerMonth contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-51347</ALRT:InterestAt1.25PerMonth>
    <ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">100000</ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth>
    <ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">100000</ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth>
    <ALRT:Iv.InterestAt0.5PerMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">695000</ALRT:Iv.InterestAt0.5PerMonth>
    <ALRT:Iv.InterestAt0.5PerMonth contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">695000</ALRT:Iv.InterestAt0.5PerMonth>
    <ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1475000</ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth>
    <ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1465000</ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth>
    <ALRT:PromissoryNotesRelatedParty contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3041966</ALRT:PromissoryNotesRelatedParty>
    <ALRT:PromissoryNotesRelatedParty contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3031966</ALRT:PromissoryNotesRelatedParty>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_hus-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zfmVfHR9hWF4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8B8_z8taTbZTu3tg" style="display: none"&gt;Schedule of activities of promissory notes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying &lt;br/&gt;Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2019 and 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NotesPayable_c20201231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="width: 18%; text-align: right" title="Balance at beginning"&gt;2,254,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified to interest payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable"&gt;(10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Extinguished through issuance of shares of common stock (note&#160;6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)"&gt;(20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred to promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;(10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NotesPayable_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zD7HUig8246i" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;2,213,368&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:NotesPayable
      contextRef="AsOf2020-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">2254353</us-gaap:NotesPayable>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">-10985</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <ALRT:ExtinguishedThroughIssuanceOfSharesOfCommonStock
      contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">-20000</ALRT:ExtinguishedThroughIssuanceOfSharesOfCommonStock>
    <ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.
      contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">-10000</ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">2213368</us-gaap:NotesPayable>
    <ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_zpc0UbGvFs87" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;&lt;span id="xdx_8BB_zpz7hl0vq7g" style="display: none"&gt;Schedule of activity of promissory notes payable to unrelated parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20211231_zKPBBWDMim39" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20201231_zc3JoB1i8zL6" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Unsecured promissory notes payable to unrelated lenders, past maturity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTz7Ci_zLtGDltQ3FV9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-indent: -0.25in; padding-left: 0.5in"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,317,456&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,337,456&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTz7Ci_zHo1MNZczqz5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;ii.&#160;&#160;&#160;&#160;&#160; Interest at 0.667% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;425,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;435,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--Vi.InterestAt0.667PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTz7Ci_zYeMkzuBzqC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;iii.&#160;&#160;&#160; Interest at 0.625% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTz7Ci_z7oSKDDrOSSh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in"&gt;iv.&#160;&#160;&#160;&#160; Non-interest-bearing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;270,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;270,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTz7Ci_z1YlDSMjUSSk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;50,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTz7Ci_ztB5hz3Likw4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Total Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,213,368&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,254,353&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock>
    <ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1317456</ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand>
    <ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1337456</ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand>
    <ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">425000</ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand>
    <ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">435985</ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand>
    <ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011 contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">150000</ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011>
    <ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011 contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">150000</ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011>
    <ALRT:Noninterestbearing contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">270912</ALRT:Noninterestbearing>
    <ALRT:Noninterestbearing contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">270912</ALRT:Noninterestbearing>
    <ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">50000</ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth>
    <ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">60000</ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth>
    <ALRT:TotalPromissoryNotesPayableToUnrelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2213368</ALRT:TotalPromissoryNotesPayableToUnrelatedParties>
    <ALRT:TotalPromissoryNotesPayableToUnrelatedParties contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2254353</ALRT:TotalPromissoryNotesPayableToUnrelatedParties>
    <us-gaap:InterestAndOtherIncomeTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--InterestAndOtherIncomeTableTextBlock_zGLsJkFb2iy9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zCPD5Eubohed" style="display: none"&gt;Scheduled of summary of interest payable activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying &lt;br/&gt;Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2019&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20200101__20201231_zSLmk8oOkf3d" style="width: 18%; text-align: right" title="Beginning Balance"&gt;5,364,997&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20200101__20201231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable"&gt;528,871&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest payable retired through issuance of shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20200101__20201231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares"&gt;(2,318,542&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_zr5LrUGdYTk4" style="text-align: right" title="Beginning Balance"&gt;3,575,326&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified from promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ReclassifiedFromPromissoryNotesPayable_iP3us-gaap--InterestPayableCurrentAndNoncurrent_pp0p0_c20210101__20211231_zNsHM9JZqh4k" style="text-align: right" title="Reclassified from promissory notes payable"&gt;10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable"&gt;527,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest payable retired through issuance of shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares"&gt;(3,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20210101__20211231_z6Tsv6Ghb2mc" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"&gt;4,110,647&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:InterestAndOtherIncomeTableTextBlock>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">5364997</us-gaap:InterestPayableCurrentAndNoncurrent>
    <ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">528871</ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables>
    <ALRT:InterestPayableRetiredThroughIssuanceOfShares
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-2318542</ALRT:InterestPayableRetiredThroughIssuanceOfShares>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3575326</us-gaap:InterestPayableCurrentAndNoncurrent>
    <ALRT:ReclassifiedFromPromissoryNotesPayable
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">10985</ALRT:ReclassifiedFromPromissoryNotesPayable>
    <ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">527336</ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables>
    <ALRT:InterestPayableRetiredThroughIssuanceOfShares
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-3000</ALRT:InterestPayableRetiredThroughIssuanceOfShares>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4110647</us-gaap:InterestPayableCurrentAndNoncurrent>
    <ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zVPkAZlxnDH5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B0_zV63rWfNbDO3" style="display: none"&gt;Schedule of Interest payable is due to related&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20211231_zF7t41xAvwze" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20201231_zpLUr2i3Rgi4" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Related parties&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,200,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;873,666&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Non-related parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,910,477&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,701,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Interest payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,110,647&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,575,326&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock>
    <ALRT:InterestPayableRelativesOfDirectors contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1200170</ALRT:InterestPayableRelativesOfDirectors>
    <ALRT:InterestPayableRelativesOfDirectors contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">873666</ALRT:InterestPayableRelativesOfDirectors>
    <ALRT:InterestPayabletoNonrelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2910477</ALRT:InterestPayabletoNonrelatedParties>
    <ALRT:InterestPayabletoNonrelatedParties contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2701660</ALRT:InterestPayabletoNonrelatedParties>
    <ALRT:InterestPayableCurrentAndNoncurrents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4110647</ALRT:InterestPayableCurrentAndNoncurrents>
    <ALRT:InterestPayableCurrentAndNoncurrents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3575326</ALRT:InterestPayableCurrentAndNoncurrents>
    <us-gaap:InterestExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">5468328</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2116466</us-gaap:InterestExpense>
    <ALRT:LineOfCreditTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_806_ecustom--LineOfCreditTextBlock_zV62d44UbMI9" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82A_zKkOtrO7YYOc"&gt;Lines
of credit&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A summary
of lines of credit activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zELvU4FBCtac" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8B6_zEamN8942x0h" style="display: none"&gt;Schedule of lines of credit activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2019&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20200101__20201231_zuL0XbpyV5j7" style="width: 18%; text-align: right" title="Balance at beginning"&gt;19,310,707&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20200101__20201231_zZqdqzTutaa1" style="text-align: right" title="Advances received on lines of credit"&gt;820,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of principal borrowed on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RepaymentsOfLinesOfCredit_iN_pp0p0_di_c20200101__20201231_z5bKtZJCM9Pd" style="text-align: right" title="Repayment of principal borrowed on lines of credit"&gt;(1,038,967&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20200101__20201231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;1,464,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--RepaymentOfInterestOnLinesOfCredit_c20200101__20201231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(8,642,491&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_zC2YdumlKOMl" style="text-align: right" title="Balance at beginning"&gt;11,914,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_pp0p0_c20210101__20211231_zSKId9WuaVbk" style="text-align: right" title="Advances received on lines of credit"&gt;1,149,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;1,402,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--RepaymentOfInterestOnLinesOfCredit_pp0p0_c20210101__20211231_zN3gJOeNFiOf" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(456,725&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20210101__20211231_zey4E85EW0Ja" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;14,008,833&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zYqwowS01pm2" style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On December
10, 2021, the Company and the spouse of the Chairman entered into an amendment agreement to increase the borrowing limit on the line
of credit provided by the spouse of the Chairman to the Company from $2,000,000 to $4,000,000. The terms of amounts to be advanced under
the amendment are consistent with the line of credit. In connection with the line of credit, the Company granted the spouse of the Chairman
the option to acquire 40,000,000 shares of common of the Company at a price of $0.05 per share until December 31, 2026 (note&#160;7).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On September&#160;21,
2020, the Company, the Chairman and the Chairman&#x2019;s spouse agreed to retire a portion of the principal of $1,038,967 and accrued
interest of $8,642,491 pursuant to two shares for debt agreements (note&#160;6(b)).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of
December&#160;31, 2021, the Company has two lines of credit as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduledOfLineOfCreditTableTextBlock_zmHYpepuNWZi" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of Credit (Details 1)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BA_zhlO2Pewlvrh" style="display: none"&gt;Schedule of lines of credit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,220,700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,208,582&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;11,429,282&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,467,705&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;111,846&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,579,551&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_905_ecustom--BorrowingLimit_iI_pp0p0_c20211231_zNLWdOkQXR0c" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_908_ecustom--PrincipalBorrowed_iI_pp0p0_c20211231_zexQ2TBUKcAe" title="Principal Borrowed"&gt;12,688,405&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_908_ecustom--AccruedInterest_iI_pp0p0_c20211231_zSXAC20xLWbb" title="Accrued Interest"&gt;1,320,428&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_901_ecustom--TotalOutstanding_iI_pp0p0_c20211231_zJ8Z1W09Db7j" title="Total Outstanding"&gt;14,008,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of
December&#160;31, 2020, the Company has two lines of credit as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--InterestRate_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_907_ecustom--BorrowingLimit_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--RepaymentTerms1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_903_ecustom--PrincipalBorrowed_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;9,539,125&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_901_ecustom--AccruedInterest_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;314,967&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--TotalOutstanding_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;9,854,092&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--Security1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--Purpose1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--InterestRate_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--BorrowingLimit_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--RepaymentTerms1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalBorrowed_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--AccruedInterest_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;60,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--TotalOutstanding_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,060,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Security1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--Purpose1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--BorrowingLimit_c20201231_pp0p0" title="Borrowing Limit"&gt;12,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90C_ecustom--PrincipalBorrowed_c20201231_pp0p0" title="Principal Borrowed"&gt;11,539,125&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90E_ecustom--AccruedInterest_c20201231_pp0p0" title="Accrued Interest"&gt;374,967&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_907_ecustom--TotalOutstanding_c20201231_pp0p0" title="Total Outstanding"&gt;11,914,092&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zG1k4gIGM4i" style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ALRT:LineOfCreditTextBlock>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zELvU4FBCtac" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8B6_zEamN8942x0h" style="display: none"&gt;Schedule of lines of credit activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2019&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20200101__20201231_zuL0XbpyV5j7" style="width: 18%; text-align: right" title="Balance at beginning"&gt;19,310,707&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20200101__20201231_zZqdqzTutaa1" style="text-align: right" title="Advances received on lines of credit"&gt;820,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of principal borrowed on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RepaymentsOfLinesOfCredit_iN_pp0p0_di_c20200101__20201231_z5bKtZJCM9Pd" style="text-align: right" title="Repayment of principal borrowed on lines of credit"&gt;(1,038,967&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20200101__20201231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;1,464,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--RepaymentOfInterestOnLinesOfCredit_c20200101__20201231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(8,642,491&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_zC2YdumlKOMl" style="text-align: right" title="Balance at beginning"&gt;11,914,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_pp0p0_c20210101__20211231_zSKId9WuaVbk" style="text-align: right" title="Advances received on lines of credit"&gt;1,149,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;1,402,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit (note&#160;6(b))&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--RepaymentOfInterestOnLinesOfCredit_pp0p0_c20210101__20211231_zN3gJOeNFiOf" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(456,725&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20210101__20211231_zey4E85EW0Ja" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;14,008,833&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">19310707</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">820766</us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1038967</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentInterest
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1464077</us-gaap:LineOfCreditFacilityPeriodicPaymentInterest>
    <ALRT:RepaymentOfInterestOnLinesOfCredit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-8642491</ALRT:RepaymentOfInterestOnLinesOfCredit>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11914092</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1149279</us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1402187</us-gaap:LineOfCreditFacilityPeriodicPaymentInterest>
    <ALRT:RepaymentOfInterestOnLinesOfCredit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-456725</ALRT:RepaymentOfInterestOnLinesOfCredit>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14008833</us-gaap:LongTermLineOfCredit>
    <ALRT:ScheduledOfLineOfCreditTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduledOfLineOfCreditTableTextBlock_zmHYpepuNWZi" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of Credit (Details 1)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BA_zhlO2Pewlvrh" style="display: none"&gt;Schedule of lines of credit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,220,700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,208,582&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;11,429,282&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,467,705&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;111,846&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,579,551&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_905_ecustom--BorrowingLimit_iI_pp0p0_c20211231_zNLWdOkQXR0c" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_908_ecustom--PrincipalBorrowed_iI_pp0p0_c20211231_zexQ2TBUKcAe" title="Principal Borrowed"&gt;12,688,405&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_908_ecustom--AccruedInterest_iI_pp0p0_c20211231_zSXAC20xLWbb" title="Accrued Interest"&gt;1,320,428&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_901_ecustom--TotalOutstanding_iI_pp0p0_c20211231_zJ8Z1W09Db7j" title="Total Outstanding"&gt;14,008,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of
December&#160;31, 2020, the Company has two lines of credit as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--InterestRate_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_907_ecustom--BorrowingLimit_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--RepaymentTerms1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_903_ecustom--PrincipalBorrowed_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;9,539,125&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_901_ecustom--AccruedInterest_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;314,967&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--TotalOutstanding_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;9,854,092&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--Security1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--Purpose1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--InterestRate_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--BorrowingLimit_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--RepaymentTerms1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--PrincipalBorrowed_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--AccruedInterest_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;60,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--TotalOutstanding_c20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,060,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Security1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--Purpose1_c20200101__20201231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_900_ecustom--BorrowingLimit_c20201231_pp0p0" title="Borrowing Limit"&gt;12,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90C_ecustom--PrincipalBorrowed_c20201231_pp0p0" title="Principal Borrowed"&gt;11,539,125&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90E_ecustom--AccruedInterest_c20201231_pp0p0" title="Accrued Interest"&gt;374,967&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_907_ecustom--TotalOutstanding_c20201231_pp0p0" title="Total Outstanding"&gt;11,914,092&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ALRT:ScheduledOfLineOfCreditTableTextBlock>
    <ALRT:InterestRate contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10300000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10220700</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">1208582</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">11429282</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:InterestRate contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">4000000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2467705</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">111846</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2579551</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:BorrowingLimit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14300000</ALRT:BorrowingLimit>
    <ALRT:PrincipalBorrowed contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">12688405</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1320428</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14008833</ALRT:TotalOutstanding>
    <ALRT:InterestRate contextRef="From2020-01-012020-12-31_custom_ChairmanAndCEOMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2020-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10300000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2020-01-012020-12-31_custom_ChairmanAndCEOMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2020-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">9539125</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2020-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">314967</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2020-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">9854092</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2020-01-012020-12-31_custom_ChairmanAndCEOMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2020-01-012020-12-31_custom_ChairmanAndCEOMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:InterestRate contextRef="From2020-01-012020-12-31_custom_WifeOfChairmanMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2020-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2000000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2020-01-012020-12-31_custom_WifeOfChairmanMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2020-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2000000</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2020-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">60000</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2020-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2060000</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2020-01-012020-12-31_custom_WifeOfChairmanMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2020-01-012020-12-31_custom_WifeOfChairmanMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:BorrowingLimit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">12300000</ALRT:BorrowingLimit>
    <ALRT:PrincipalBorrowed contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11539125</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">374967</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11914092</ALRT:TotalOutstanding>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zLKUiqXOJD1k" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_820_zEyaTHifqFa"&gt;Capital
stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&#160;&#160;&#160;&#160;&#160;&#160;
Authorized share capital&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common
                                            stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000,000
shares of common stock with a par value of $0.001 per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred
                                            stock &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;500,000,000
shares of preferred stock with a par value of $0.001 per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&#160;&#160;&#160;&#160;&#160;
Issued share capital&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;During
the year ended December&#160;31, 2021:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 4, 2021, 1,000 shares of common stock were cancelled by a shareholder; no consideration
                                            was exchanged.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            April 12, 2021, the Company elected to extend the initial 90-day period (April 22, 2021)
                                            by an additional 100-day period related to the closing of the rights offering. The Company
                                            had until July&#160;31, 2021 to sell the remaining 113,025,592 shares of common stock. The
                                            Company further extended the offering period to October 29, 2021. The Company filed a post-effective
                                            amendment to further extend the rights offering from October 29, 2021 to March 15, 2022.
                                            On such case-by-case basis, the Company will allow for the exercise of any such shareholders
                                            until April 1, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company collected subscriptions of $1,124,832 pursuant to its registration statement and
                                            issued a total of 26,496,635 shares of common stock for gross proceeds of $1,324,832; $200,000
                                            of the proceeds had been collected during the year ended December&#160;31, 2020 and recognized
                                            as obligation to issue shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company received proceeds of $12,000 pursuant to the exercise of options to acquire 800,000
                                            shares of common stock at a price of $0.015 per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;




























&lt;p style="margin: 0 0 0 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;v.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company entered into two shares for debt agreements with two creditors to issue an aggregate
                                            4,400,000 shares of common stock at a fair value of $0.057 per share for a purchase price
                                            of $250,800 in exchange for the retirement of $217,186 of liabilities comprised of: &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 15%"/&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Symbol; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: justify; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: right; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;194,186&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: justify; width: 25%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 15%"/&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Symbol; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory notes &#x2013; Principal&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: justify; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: right; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,000&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: justify; width: 25%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 15%"/&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Symbol; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Line of credit &#x2013; Accrued interest &lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: justify; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: right; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,000&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: justify; width: 25%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;The Company recognized loss on debt settlement
of $33,614. The Company also issued commitment letters to two creditors offering them an aggregate 20,000,000 shares of common stock in
exchange for the extinguishment of $1,511,377 in promissory notes and interest payable prior to December&#160;31, 2021 (notes&#160;8 and
14). These offer letters expired on December 31, 2021 without the parties executing any settlements. On March 18, 2022, the Company extended
the offer letters from December 31, 2021 to December 31, 2022 for the settlement of $1,541,000 in promissory notes and interest payable.&lt;/p&gt;
&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;During
the year ended December&#160;31, 2020:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            February 11, 2020, the Company issued 2,000,000 restricted shares of common stock at a price
                                            of $0.04 per share with a value of $80,000 in exchange for the retirement of $60,000 of accounts
                                            payable and $20,000 for the provision of services. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            August 24, 2020, the Company issued 242,800 restricted shares of common stock at a price
                                            of $0.05 per share for proceeds of $12,140. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            September 21, 2020, the Company entered into two shares for debt agreements with the Chairman
                                            and his spouse to issue an aggregate 240,000,000 restricted shares of common stock at a price
                                            of $0.05 per share for a purchase price of $12,000,000 in exchange for the retirement of
                                            $12,000,000 of liabilities comprised of: &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 15%"/&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Symbol; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory notes &#x2013; Accrued interest&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: justify; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: right; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,318,542&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 15%"/&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Symbol; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Line
of credit &#x2013; Accrued interest&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: justify; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: right; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,642,491&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 15%"/&gt;&lt;td style="width: 3%"&gt;&lt;span style="font-family: Symbol; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Line of credit &#x2013; Principal &lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: justify; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
                                                                                                                              &lt;td style="text-align: right; width: 12%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,038,967&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 25%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;


&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            December 4, 2020, the Company filed a Form S-1 Registration Statement to distribute subscription
                                            rights to purchase up to an aggregate 127,522,227 shares of common stock at a price of $0.05
                                            per share for maximum aggregate offering proceeds of $6,376,111. The Company collected subscriptions
                                            of $200,000 related to management&#x2019;s right to allocate unsubscribed shares of common
                                            stock. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
















</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <ALRT:AdditionalPaidInCapitalTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80C_ecustom--AdditionalPaidInCapitalTextBlock_z8zucxlBcqC2" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_828_z543hHbsGMBh"&gt;Additional
paid-in capital &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
options&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zlayo1ESMob3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_z2OrIpC0F0A2" style="display: none"&gt;Schedule of share-based compensation, stock options, activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December&#160;31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 5.4pt"&gt;Outstanding, beginning of year&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_z5LLWgijAtah" style="width: 10%; text-align: right" title="Outstanding, beginning of period"&gt;5,362,701,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zivh4EnPsfdl" style="width: 10%; text-align: right" title="Average Exercise Price, beginning"&gt;0.004&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231_z97TfeCUMwb3" style="width: 10%; text-align: right"&gt;5,236,401,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231_zq03gLsehzZh" style="width: 10%; text-align: right"&gt;0.003&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="text-align: right" title="Granted"&gt;165,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="text-align: right" title="Granted, per share"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200101__20201231_pdd" style="text-align: right" title="Granted"&gt;139,800,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231_pdd" style="text-align: right" title="Granted, per share"&gt;0.047&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_zjeMQsKNd7Fk" style="text-align: right" title="Exercised"&gt;(800,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_zcymRJMStm3i" style="text-align: right" title="Exercised per share"&gt;(0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20200101__20201231_zuZUKMtjO1l3" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0787"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20200101__20201231_zNxLJBxfKkoh" style="text-align: right" title="Exercised per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0789"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled"&gt;(29,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--CancelledPerShares_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled per share"&gt;(0.034&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_c20200101__20201231_zNzdLo1N9ZMg" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled"&gt;(13,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--CancelledPerShares_c20200101__20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled per share"&gt;(0.034&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Outstanding, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_znOFjh1bQYw6" style="border-bottom: Black 1pt solid; text-align: right" title="Outstanding, end of period"&gt;5,497,001,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zW6ViNWFlgP2" style="border-bottom: Black 1pt solid; text-align: right" title="Average Exercise price, ending"&gt;0.006&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200101__20201231_zqDRGZXfA3Gk" style="border-bottom: Black 1pt solid; text-align: right"&gt;5,362,701,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_zJnR9995uA72" style="border-bottom: Black 1pt solid; text-align: right"&gt;0.004&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Exercisable, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable, end of period"&gt;5,221,701,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20211231_zS6NlVx901" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable, end of period"&gt;0.004&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable, end of period"&gt;5,202,701,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable, end of period"&gt;0.003&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_z8YZNEu0VA0k" style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;During
the year ended December&#160;31, 2021:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On January
28, 2021, the Company granted the option to acquire an aggregate 32,000,000 shares of common stock at a price of $0.05 per share to six
individuals. All of the options will vest according to performance or time-based conditions. Options to acquire 22,000,000 shares of
common stock will expire December&#160;31, 2025, and options to acquire 10,000,000 shares of common stock will expire May&#160;17, 2024.
As at December 31, 2021, 1,000,000 options have vested to date. The fair value of the options granted totals $1,706,244, of which $573,292
relates to stock options that have time-based vesting conditions and $1,132,952 relates to stock options that have performance vesting
conditions. During the current year, $248,189 relates to the stock options with time-based vesting conditions, which was recorded. The
remaining fair value of $1,458,055 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On February
22, 2021, the Company granted the option to acquire an aggregate 5,000,000 shares of common stock at a price of $0.05 per share. These
options were granted to three individuals and have an expiry date of May 17, 2024. None of these options have vested to date. The fair
value of the options granted totals $225,141. During the current year, $57,730 related to stock options with time-based vesting conditions
was recognized. The remaining fair value of $167,411 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






























&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On April
14, 2021, the Company&#x2019;s Board of Directors approved the grant of the option to acquire an aggregate 28,500,000 shares of common
stock at a price of $0.05 per share until December&#160;31, 2025 to five individuals. All of the options will vest according to performance
or time-based conditions; 200,000 options have vested to date. The fair value of the options granted totals $1,565,812, of which $351,621
relates to stock options that have time-based vesting conditions and $1,214,191 relates to stock options that have performance vesting
conditions. During the current year, $88,540 related to the stock options with time-based vesting conditions was recognized. The remaining
fair value of $1,477,272 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On May
12, 2021, the Company&#x2019;s Board of Directors amended the option to acquire 2,000,000 shares, previously granted on January 28, 2021
to a consultant, to increase the option by 1,000,000 to provide the optionee the option to acquire an aggregate 3,000,000 shares of common
stock at a price of $0.05 per share until December&#160;31, 2025. All other terms of the January 28, 2021 grant remain the same and the
options are subject to performance vesting conditions. The fair value of the additional 1,000,000 amended options granted totaling $54,940
was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On May
31, 2021, the Company granted one consultant the option to acquire 5,000,000 shares of common stock of the Company at a price of $0.05
per share until December&#160;31, 2025 subject to performance vesting conditions. The fair value of the options granted totaling $254,708
was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On June
27, 2021, the Company cancelled 7,400,000 stock options with an average exercise price of $0.033.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On June
27, 2021, the Company&#x2019;s Board of Directors approved the grant of the option to acquire an aggregate 21,000,000 shares of common
stock at a price of $0.05 per share until June&#160;30, 2026 to four individuals. All of the options will vest according to performance
or time-based conditions. The fair value of the options granted totals $1,374,208, of which $26,175 relates to stock options that have
time-based vesting conditions and $1,348,033 relates to stock options that have performance vesting conditions. During the current year,
$9,816 related to the stock options with time-based vesting conditions was recognized. The remaining fair value of $1,364,392 has not
been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On June
30, 2021, the Company amended the option to acquire 4,365,001,300 shares of common stock granted on July&#160;1, 2016 by extending the
expiry date from July&#160;1, 2021 to April&#160;12, 2024. The options were granted in connection with lines of credit provided by the
Chairman and his spouse, which are currently outstanding (note&#160;5). All of the options had vested in previous years. The fair value
of the amendments totaled $1,287,834 and was recorded during the current period in interest expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
































&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
July 22, 2021, the Company cancelled 22,500,000 stock options exercisable at $0.035 related to the termination of certain contractors
and advisors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On August
27, 2021, the Company granted a member of the Board of Directors the option to acquire 5,000,000 shares of common stock at a price of
$0.05 per share until June&#160;30, 2026. The fair value of the options granted totaling $304,692 was fully recorded at grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On October
4, 2021, the Company granted two individuals the option to acquire an aggregate 17,500,000 options at an exercise price of $0.05 per
share until September&#160;30, 2026; 15,000,000 of the options will vest according to time-based conditions and 2,500,000 will vest according
to performance conditions. None of the options have vested to date. The fair value of the options granted totals $1,043,690, of which
$894,592 relates to stock options that have time-based vesting conditions and $149,098 relates to stock options that have performance
vesting conditions. During the current year, $101,758 related to the stock options with time-based vesting conditions was recognized.
The remaining fair value of $941,932 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On December
10, 2021, the Company granted one creditor the option to acquire 40,000,000 shares of common stock of the Company at a price of $0.05
per share until December&#160;31, 2026 in connection with receiving line of credit financing (note&#160;5). The fair value of the options
granted totaled $2,137,286 and was fully recorded upon the Company entering into the financing agreement with the creditor.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On December
10, 2021, the Company granted one consultant the option to acquire 10,000,000 shares of common stock of the Company at a price of $0.05
per share until December&#160;31, 2026 subject to performance vesting conditions. The fair value of the options granted totaling $534,321
was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December&#160;31, 2021, the Company recorded a further $167,373 in compensation expense related to the vesting of stock
options granted in previous years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


























&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;During
the year ended December&#160;31, 2020:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On April
1, 2020, the Company granted one consultant the option to acquire 10,000,000 shares of common stock at a price of $0.035 per share for
a term of five years. The fair value of the options granted totaling $391,843 was fully recorded at grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On May
12, 2020, the Company amended the option to acquire 40,000,000 shares of common stock granted on June 12, 2019 to extend the period of
vesting from May 31, 2020 to December&#160;31, 2020. None of these options have vested to date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On May
18, 2020, the Company granted one consultant the option to acquire 500,000 shares of common stock of the Company at a price of $0.035
per share until May 17, 2024. The fair value of the options granted totaling $18,725 was fully recorded at grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On June
1, 2020, the Company granted one consultant the option to acquire 10,000,000 shares of common stock of the Company at a price of $0.035
per share until May 31, 2025 subject to performance vesting conditions. The fair value of the options granted totaling $621,853 was not
recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On June
5, 2020, the Company granted one sales agent the option to acquire 10,000,000 shares of common stock of the Company at a price of $0.035
per share until May 31, 2025 subject to the agent enrolling 20,000 patients into the ALRT Diabetes Solution by May 31, 2021. The fair
value of the options granted totaling $494,868 was not recorded, as it cannot be determined that it is more likely than not that the
performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On September
1, 2020, the Company granted 13 individuals the option to acquire an aggregate 74,500,000 options at an exercise price of $0.05 per share;
22,000,000 stock options, which vested at the time of grant, will expire on May 17, 2024 and 52,500,000 stock options, which vest upon
achievement of performance conditions, will expire on May 31, 2025. None of the stock options with performance vesting conditions have
vested. The fair value of the options granted totals $3,854,619, of which $1,137,397 related to the stock options that have vested was
recorded and $2,717,222 related to the options that have not vested was not recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On October
12, 2020, the Company granted eight individuals the option to acquire an aggregate 34,800,000 options at an exercise price of $0.05 per
share until May 31, 2025; 18,300,000 vested at the time of grant and 16,500,000 of the stock options granted will vest upon achievement
of performance conditions. None of the stock options with performance vesting conditions had vested as at December 31, 2020 and 1,000,000
vested during the year ended December 31, 2021. The fair value of the options granted totaled $2,434,053, of which $1,279,973 related
to the stock options that have vested was recorded and $1,154,080 related to the options that have not vested was not recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






























&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2020, the Company recorded a further $79 in compensation expense relating to the vesting of stock options
granted in previous years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
options outstanding at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleofOptionsOutstandingTableTextBlock_z0oQOZDvHdcc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional Paid-in Capital (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zq7Wsu6dBO4k" style="display: none"&gt;Schedule of Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Expiry Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Intrinsic Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Intrinsic Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; padding-left: 5.4pt"&gt;July 1, 2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0866"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Exercise Price"&gt;0.002&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_z8XY0Med44f3" style="width: 6%; text-align: right" title="Intrinsic Value"&gt;0.058&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Options"&gt;4,365,001,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Exercise Price"&gt;0.002&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Intrinsic Value"&gt;0.069&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;November 27, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Options"&gt;5,600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zPbKc8W5O5l4" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Options"&gt;6,950,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;January 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Options"&gt;40,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_z5cC04E9I2Xd" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Options"&gt;40,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;June 13, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zkPtfBySVjc4" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;October 1, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0914"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_z3VxbU0anRkh" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Options"&gt;300,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;February 3, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zq3eDvuovUE6" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Options"&gt;10,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;March 14, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Options"&gt;6,650,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Options"&gt;9,150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;April 12, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Options"&gt;4,925,001,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.002&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.058&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Options"&gt;560,000,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.002&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.069&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;April 12, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Options"&gt;3,350,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Options"&gt;3,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;April 12, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Options"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.030&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.030&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Options"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.030&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 6, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Options"&gt;13,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Options"&gt;13,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Options"&gt;77,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Options"&gt;62,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Options"&gt;19,400,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Options"&gt;25,400,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;June 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;June 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1034"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;August 16, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Options"&gt;2,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Options"&gt;2,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;September 6, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Options"&gt;1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Options"&gt;1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;September 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1070"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;October 3, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Options"&gt;3,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Options"&gt;3,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;October 24, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Options"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Options"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;December 11, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Options"&gt;120,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Options"&gt;120,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;April 1, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Options"&gt;10,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Options"&gt;10,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Options"&gt;20,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Options"&gt;20,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Options"&gt;87,300,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Options"&gt;87,300,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;December&#160;31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Options"&gt;56,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1160"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Exercise Price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1164"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;June&#160;30, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Options"&gt;26,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1172"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Exercise Price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1174"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1176"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;September&#160;30, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Options"&gt;17,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1184"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Exercise Price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1186"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1188"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;December&#160;31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options"&gt;50,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_zC2ZyjSo9URd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_z1ImGnIfqQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1196"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_znC5lOYOOgm8" style="border-bottom: Black 1pt solid; text-align: right" title="Exercise Price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1198"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_zbArxwVPxHZ5" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1200"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options"&gt;5,497,001,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercise Price"&gt;0.006&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231_zDdFgqFJ3bPc" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value"&gt;0.054&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options"&gt;5,362,701,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExercisePrices_c20200101__20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercise Price"&gt;0.004&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntrinsicValue_c20200101__20201231_zY6g5u2gOgl" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value"&gt;0.066&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Weighted Average Remaining Contractual Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zBM10Db1cVog" title="Weighted Average Remaining Contractual Life"&gt;2.37&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231_z1qoGhFDkWIb" title="Weighted Average Remaining Contractual Life"&gt;1.05&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AD_ziX2bKyeNsTg" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the stock options granted and vested was allocated as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zrkXUZ9kT5ua" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B9_zzlwX0K15ymh" style="display: none"&gt;Schedule of Fair Value of Stock Options Granted-Allocation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20210101_20211231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20200101_20201231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--InterestExpenseOther_maTzMNs_z2SMvdQfOBOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Interest expense&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,425,120&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTzMNs_zmHfqflQfJyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Product development expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;222,178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,156,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfessionalAndContractServicesExpense_maTzMNs_zA5yrhtMrTQl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Professional expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;169,382&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;741,564&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTzMNs_zpkqV6iJRAA3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Selling, general and administration expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;586,538&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;930,258&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--Total_iT_mtTzMNs_zJJy6ahsXaF5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Fair value of the stock options granted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,403,218&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,828,017&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zSYyecOuJwsc" style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair
value was determined using the Black-Scholes option pricing model based on the following weighted average assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zgTvpnoC6Bjc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional Paid-in Capital (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B8_zMJaaZIBIilk" style="display: none"&gt;Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zzTqeBfNy3Ek" title="Risk-free interest rate"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20200101__20201231_zjn2xxML4Kcj" title="Risk-free interest rate"&gt;0.20&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zPdqaAgJ3zH9" title="Expected life"&gt;4.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231_zMmOzynBgSR3" title="Expected life"&gt;4.6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20211231_ziRBVeJfZ1Ck" title="Expected dividends"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20200101__20201231_zq2RF2KVm6qf" title="Expected dividends"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_zyr8LVo4hILe" title="Expected volatility"&gt;278&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20200101__20201231_z8SYhow23E38" title="Expected volatility"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Forfeiture rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20211231_zB0jYsxc9GX4" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20200101__20201231_zsf4AzsJBr4f" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zxiTR8z3ARS7" style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
weighted average fair value for the options granted during 2021 was $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z8LpQvuFaUk3" title="Weighted average fair value options granted"&gt;0.06&lt;/span&gt; (2020&#160;- $&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zNb3KAZZClAg"&gt;0.06&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</ALRT:AdditionalPaidInCapitalTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zlayo1ESMob3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8B2_z2OrIpC0F0A2" style="display: none"&gt;Schedule of share-based compensation, stock options, activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December&#160;31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number of Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 5.4pt"&gt;Outstanding, beginning of year&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_z5LLWgijAtah" style="width: 10%; text-align: right" title="Outstanding, beginning of period"&gt;5,362,701,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zivh4EnPsfdl" style="width: 10%; text-align: right" title="Average Exercise Price, beginning"&gt;0.004&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231_z97TfeCUMwb3" style="width: 10%; text-align: right"&gt;5,236,401,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231_zq03gLsehzZh" style="width: 10%; text-align: right"&gt;0.003&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="text-align: right" title="Granted"&gt;165,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="text-align: right" title="Granted, per share"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200101__20201231_pdd" style="text-align: right" title="Granted"&gt;139,800,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231_pdd" style="text-align: right" title="Granted, per share"&gt;0.047&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_zjeMQsKNd7Fk" style="text-align: right" title="Exercised"&gt;(800,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_zcymRJMStm3i" style="text-align: right" title="Exercised per share"&gt;(0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20200101__20201231_zuZUKMtjO1l3" style="text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0787"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20200101__20201231_zNxLJBxfKkoh" style="text-align: right" title="Exercised per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0789"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled"&gt;(29,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--CancelledPerShares_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled per share"&gt;(0.034&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_c20200101__20201231_zNzdLo1N9ZMg" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled"&gt;(13,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--CancelledPerShares_c20200101__20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled per share"&gt;(0.034&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Outstanding, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_znOFjh1bQYw6" style="border-bottom: Black 1pt solid; text-align: right" title="Outstanding, end of period"&gt;5,497,001,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zW6ViNWFlgP2" style="border-bottom: Black 1pt solid; text-align: right" title="Average Exercise price, ending"&gt;0.006&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200101__20201231_zqDRGZXfA3Gk" style="border-bottom: Black 1pt solid; text-align: right"&gt;5,362,701,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_zJnR9995uA72" style="border-bottom: Black 1pt solid; text-align: right"&gt;0.004&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Exercisable, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable, end of period"&gt;5,221,701,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20211231_zS6NlVx901" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable, end of period"&gt;0.004&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable, end of period"&gt;5,202,701,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercisable, end of period"&gt;0.003&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">5362701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">5236401500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">165000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.050</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">139800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.047</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">800000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.015</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">-29900000</ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations>
    <ALRT:CancelledPerShares
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">-0.034</ALRT:CancelledPerShares>
    <ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">-13500000</ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations>
    <ALRT:CancelledPerShares
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">-0.034</ALRT:CancelledPerShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">5497001500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">5362701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">5221701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">5202701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <ALRT:ScheduleofOptionsOutstandingTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduleofOptionsOutstandingTableTextBlock_z0oQOZDvHdcc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional Paid-in Capital (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zq7Wsu6dBO4k" style="display: none"&gt;Schedule of Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Expiry Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Intrinsic Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Intrinsic Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; padding-left: 5.4pt"&gt;July 1, 2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0866"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Exercise Price"&gt;0.002&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_z8XY0Med44f3" style="width: 6%; text-align: right" title="Intrinsic Value"&gt;0.058&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Options"&gt;4,365,001,300&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Exercise Price"&gt;0.002&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="width: 6%; text-align: right" title="Intrinsic Value"&gt;0.069&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;November 27, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Options"&gt;5,600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_zPbKc8W5O5l4" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Options"&gt;6,950,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;January 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Options"&gt;40,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_z5cC04E9I2Xd" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Options"&gt;40,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;June 13, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_zkPtfBySVjc4" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;October 1, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0914"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_z3VxbU0anRkh" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Options"&gt;300,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;February 3, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_zq3eDvuovUE6" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Options"&gt;10,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;March 14, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Options"&gt;6,650,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Options"&gt;9,150,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;April 12, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Options"&gt;4,925,001,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.002&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.058&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Options"&gt;560,000,200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.002&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.069&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;April 12, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Options"&gt;3,350,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Options"&gt;3,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;April 12, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Options"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.030&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.030&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Options"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.030&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.041&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 6, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Options"&gt;13,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Options"&gt;13,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Options"&gt;77,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Options"&gt;62,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Options"&gt;19,400,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Options"&gt;25,400,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;June 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;June 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1034"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;August 16, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Options"&gt;2,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Options"&gt;2,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;September 6, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Options"&gt;1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Options"&gt;1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;September 17, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1070"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Options"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;October 3, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Options"&gt;3,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Options"&gt;3,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;October 24, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Options"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Options"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;December 11, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Options"&gt;120,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Options"&gt;120,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;April 1, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Options"&gt;10,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Options"&gt;10,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Options"&gt;20,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Options"&gt;20,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.036&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;May 31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Options"&gt;87,300,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Options"&gt;87,300,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options24Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;December&#160;31, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Options"&gt;56,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1160"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Exercise Price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options25Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1164"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;June&#160;30, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Options"&gt;26,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1172"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Exercise Price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1174"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options26Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1176"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;September&#160;30, 2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Options"&gt;17,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1184"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Exercise Price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1186"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options27Member_pdd" style="text-align: right" title="Intrinsic Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1188"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;December&#160;31, 2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options"&gt;50,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_zC2ZyjSo9URd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercise Price"&gt;0.050&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_z1ImGnIfqQ2" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value"&gt;0.010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1196"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisePrices_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_znC5lOYOOgm8" style="border-bottom: Black 1pt solid; text-align: right" title="Exercise Price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1198"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--IntrinsicValue_c20200101__20201231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options28Member_zbArxwVPxHZ5" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1200"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options"&gt;5,497,001,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercise Price"&gt;0.006&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231_zDdFgqFJ3bPc" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value"&gt;0.054&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20200101__20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Options"&gt;5,362,701,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExercisePrices_c20200101__20201231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Exercise Price"&gt;0.004&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--IntrinsicValue_c20200101__20201231_zY6g5u2gOgl" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value"&gt;0.066&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Weighted Average Remaining Contractual Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zBM10Db1cVog" title="Weighted Average Remaining Contractual Life"&gt;2.37&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231_z1qoGhFDkWIb" title="Weighted Average Remaining Contractual Life"&gt;1.05&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ALRT:ScheduleofOptionsOutstandingTableTextBlock>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.002</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.058</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="Shares">4365001300</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.002</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.069</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="Shares">5600000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="Shares">6950000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.056</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="Shares">40500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="Shares">40500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.056</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.056</ALRT:IntrinsicValue>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="Shares">300000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.021</ALRT:IntrinsicValue>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="Shares">10000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="Shares">6650000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="Shares">9150000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="Shares">4925001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.002</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.058</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="Shares">560000200</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.002</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.069</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="Shares">3350000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="Shares">3900000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.056</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="Shares">200000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.030</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.030</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="Shares">200000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.030</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.041</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="Shares">13000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="Shares">13000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="Shares">77000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="Shares">62000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="USDPShares">0.021</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="Shares">19400000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="Shares">25400000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.021</ALRT:IntrinsicValue>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="Shares">2500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="Shares">2500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.021</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="Shares">1000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="Shares">1000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.021</ALRT:IntrinsicValue>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="Shares">3500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="Shares">3500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="Shares">2000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="Shares">2000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="Shares">120000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="Shares">120000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.056</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="Shares">10000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="Shares">10000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="Shares">20000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="Shares">20000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.036</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options24Member"
      decimals="INF"
      unitRef="Shares">87300000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options24Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options24Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31_custom_Options24Member"
      decimals="INF"
      unitRef="Shares">87300000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31_custom_Options24Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31_custom_Options24Member"
      decimals="INF"
      unitRef="USDPShares">0.021</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options25Member"
      decimals="INF"
      unitRef="Shares">56500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options25Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options25Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options26Member"
      decimals="INF"
      unitRef="Shares">26000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options26Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options26Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options27Member"
      decimals="INF"
      unitRef="Shares">17500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options27Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options27Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options28Member"
      decimals="INF"
      unitRef="Shares">50000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options28Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options28Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">5497001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.006</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.054</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">5362701500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.004</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.066</ALRT:IntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-01to2021-12-31">P2Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-012020-12-31">P1Y18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zrkXUZ9kT5ua" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B9_zzlwX0K15ymh" style="display: none"&gt;Schedule of Fair Value of Stock Options Granted-Allocation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20210101_20211231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20200101_20201231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--InterestExpenseOther_maTzMNs_z2SMvdQfOBOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Interest expense&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,425,120&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTzMNs_zmHfqflQfJyk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Product development expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;222,178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,156,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfessionalAndContractServicesExpense_maTzMNs_zA5yrhtMrTQl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Professional expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;169,382&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;741,564&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTzMNs_zpkqV6iJRAA3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Selling, general and administration expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;586,538&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;930,258&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--Total_iT_mtTzMNs_zJJy6ahsXaF5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Fair value of the stock options granted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,403,218&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,828,017&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:InterestExpenseOther
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">3425120</us-gaap:InterestExpenseOther>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">222178</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1156195</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">169382</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">741564</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">586538</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">930258</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <ALRT:Total
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">4403218</ALRT:Total>
    <ALRT:Total
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2828017</ALRT:Total>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zgTvpnoC6Bjc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional Paid-in Capital (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B8_zMJaaZIBIilk" style="display: none"&gt;Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zzTqeBfNy3Ek" title="Risk-free interest rate"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20200101__20201231_zjn2xxML4Kcj" title="Risk-free interest rate"&gt;0.20&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zPdqaAgJ3zH9" title="Expected life"&gt;4.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231_zMmOzynBgSR3" title="Expected life"&gt;4.6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20211231_ziRBVeJfZ1Ck" title="Expected dividends"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20200101__20201231_zq2RF2KVm6qf" title="Expected dividends"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_zyr8LVo4hILe" title="Expected volatility"&gt;278&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20200101__20201231_z8SYhow23E38" title="Expected volatility"&gt;312&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Forfeiture rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20211231_zB0jYsxc9GX4" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20200101__20201231_zsf4AzsJBr4f" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.0087</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.0020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-01to2021-12-31">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-01-012020-12-31">P4Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">2.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">3.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zQgqTki5Mtcf" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_823_zjcgABlajZKl"&gt;Related
party transactions and balances&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zu8uTkwTRs5d" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions and Balances (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;&lt;span id="xdx_8B3_z2iJTAusioP2" style="display: none"&gt;Schedule of related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20210101__20211231_zSYYM6tKw6g1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20200101__20201231_zs0TW7bonsRk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Related party transactions included within interest expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_z1IauVojror5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;316,504&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;315,926&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_zFGcDwV6Me8g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,402,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,464,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided_zXTLwITHukz4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--InterestExpenseRelatedToStockOptionsGrantedToSpouseOfChairmanAndChiefExecutiveOfficerOfCompanyRelatedToIncreaseOfBorrowingLimitOfLineOfCredit_zZ2l050fke6d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense related to stock options granted to the spouse of the Chairman and Chief Executive Officer of the Company related to the increase of the borrowing limit of a line of credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,137,286&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1294"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Related party transactions included within selling, general and administration expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_zzLDTbRYFIgi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;249,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;249,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_zBWy25pgk4Eh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;33,427&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1303"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_zsTyOAT9OND4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Rent paid to a company controlled by the spouse of the Chairman and immediate family members&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;24,390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1306"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--StockOptionsGrantedToMemberOfBoardOfDirectorsOfCompany_zMUxOxY7Wo85" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Stock options granted to a member of the Board of Directors of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;304,692&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1309"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany_z8SjvAHv6z06" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1312"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z3yDr5UKozhd" style="margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
on promissory notes payable, interest on lines of credit payable to related parties, management compensation and compensation paid to
a relative of a director have been recorded at the exchange amount, which is the amount agreed to by the parties. Stock options granted
to related parties and modification of stock options held by related parties have been recorded at their estimated fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The Company also issued commitment letters
to two creditors who are relatives of the Chairman and Chief Executive Officer of the Company offering them an aggregate 20,000,000 shares
of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and interest payable prior to December&#160;31, 2021
(notes&#160;6(b)(v) and 14). These offer letters expired on December 31, 2021 without the parties executing any settlements. On March
18, 2022, the Company extended the offer letters from December 31, 2021 to December&#160;31, 2022 for the settlement of $1,541,000 in
promissory notes and interest payable.&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
















</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zu8uTkwTRs5d" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related Party Transactions and Balances (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;&lt;span id="xdx_8B3_z2iJTAusioP2" style="display: none"&gt;Schedule of related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20210101__20211231_zSYYM6tKw6g1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20200101__20201231_zs0TW7bonsRk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended December 31, 2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Related party transactions included within interest expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_z1IauVojror5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;316,504&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;315,926&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_zFGcDwV6Me8g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,402,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,464,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided_zXTLwITHukz4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--InterestExpenseRelatedToStockOptionsGrantedToSpouseOfChairmanAndChiefExecutiveOfficerOfCompanyRelatedToIncreaseOfBorrowingLimitOfLineOfCredit_zZ2l050fke6d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense related to stock options granted to the spouse of the Chairman and Chief Executive Officer of the Company related to the increase of the borrowing limit of a line of credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,137,286&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1294"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Related party transactions included within selling, general and administration expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_zzLDTbRYFIgi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;249,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;249,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_zBWy25pgk4Eh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Salary for services as VP Corporate and Director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;33,427&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1303"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_zsTyOAT9OND4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Rent paid to a company controlled by the spouse of the Chairman and immediate family members&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;24,390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1306"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--StockOptionsGrantedToMemberOfBoardOfDirectorsOfCompany_zMUxOxY7Wo85" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Stock options granted to a member of the Board of Directors of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;304,692&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1309"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany_z8SjvAHv6z06" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1312"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">316504</ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">315926</ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1402187</ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse>
    <ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1464077</ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse>
    <ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1287834</ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided>
    <ALRT:InterestExpenseRelatedToStockOptionsGrantedToSpouseOfChairmanAndChiefExecutiveOfficerOfCompanyRelatedToIncreaseOfBorrowingLimitOfLineOfCredit
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">2137286</ALRT:InterestExpenseRelatedToStockOptionsGrantedToSpouseOfChairmanAndChiefExecutiveOfficerOfCompanyRelatedToIncreaseOfBorrowingLimitOfLineOfCredit>
    <ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">249600</ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany>
    <ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">249600</ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany>
    <ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">33427</ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">24390</ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers>
    <ALRT:StockOptionsGrantedToMemberOfBoardOfDirectorsOfCompany
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">304692</ALRT:StockOptionsGrantedToMemberOfBoardOfDirectorsOfCompany>
    <ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">16800</ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany>
    <us-gaap:CompensationRelatedCostsGeneralTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80A_eus-gaap--CompensationRelatedCostsGeneralTextBlock_zhxJ8Al7oieg" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_828_z6Y8SHnDaiol"&gt;Commitments
and contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&#160;&#160;&#160;&#160;&#160;&#160;
Contingencies &lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
has had three judgments against it relating to overdue promissory notes and accrued interest, and a fourth creditor has demanded repayment
of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related accrued
interest and could be subject to further action. The legal liability, totaling $1,253,182, of these promissory notes and related accrued
interest have been fully recognized and recorded by the Company. The Company has accrued interest of $279,457 related to one of these
promissory notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On December
22, 2020, a default judgment was entered against the Company in regard to one of the above noted judgments totaling $551,576, consisting
of the principal amount of $300,000 and accrued interest of $251,576, as of the date of the Civil Summons.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&#160;&#160;&#160;&#160;&#160;
Commitments &lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
                                            contract &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company. Under
the terms of the contract, Mr. Chan will be paid $240,000 per annum for services as Chief Executive Officer. The contract can be terminated
at any time with thirty days&#x2019; notice and the payment of two years&#x2019; annual salary. Should the contract be terminated, all
debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically
renews for continuous one-year terms. Also, under the terms of the contract are the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Incentive
                                            revenue bonus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr. Chan
will be entitled to a 1% net sales commission from the sales of any of the Company&#x2019;s products at any time during his life, regardless
if Mr. Chan is still under contract with the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sale
                                            of business&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If more than
50% of the Company&#x2019;s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements based on the
selling price of the Company or its assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2%
                                            of sales price up to $24,999,999 plus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3%
                                            of sales price between $25,000,000 and $49,999,999 plus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4%
                                            of sales price between $50,000,000 and $199,999,999 plus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5%
                                            of sales price in excess of $200,000,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
                                            commitments &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
has a lease agreement for the Singapore office with remaining obligation of $24,450.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</us-gaap:CompensationRelatedCostsGeneralTextBlock>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_808_eus-gaap--FinancialInstrumentsDisclosureTextBlock_zygMzb2Whav3" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_829_zTH3PwZyWEkf"&gt;Financial
instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s
financial instruments consist of cash, accounts payable, interest payable, promissory notes payable to unrelated parties, promissory
notes payable to related parties and lines of credit from related parties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
                                            value &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The fair
values of cash and certain accounts payable approximate their carrying values due to the relatively short periods to maturity of these
instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
accounts payable have been outstanding longer than one year. The Company has recorded imputed interest at a rate of 1% per month over
the period the payables have been outstanding for longer than one year, with a corresponding amount recognized in additional paid-in
capital. The calculated amount represents the implicit compensation for the use of funds beyond a reasonable term for regular trade payables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the
purposes of fair value analysis, promissory notes payable to related parties and promissory notes payable to unrelated parties can be
separated into two classes of financial liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest-bearing
                                            promissory notes, lines of credit and related interest payable; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-interest-bearing
                                            promissory notes past due.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The interest-bearing
promissory notes payable are all delinquent and have continued to accrue interest at their stated rates. The Company currently does not
have the funds to extinguish these debts and will continue to incur interest until such time as the liabilities are extinguished. There
is not an active market for delinquent loans for a Company with a similar financial position. Management asserts the carrying values
of the promissory notes and related interest payable are a reasonable estimate of fair value, as they represent the Company&#x2019;s best
estimate of their legal obligation for these debts. As there is no observable market for interest rates on similar promissory notes,
the fair value was estimated using Level 2 inputs in the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
has one non-interest-bearing promissory note payable past due. There is not an active market for default loans not bearing interest nor
is there an observable market for lending to companies with a financial position similar to the Company. The Company has recorded imputed
interest at a rate of 1% per month over the life of the promissory notes, with a corresponding amount recognized in additional paid-in
capital representing the implicit compensation for the use of funds. Management asserts the payment date for these amounts cannot be
reasonably determined. Management further asserts there is not a determinable interest rate for arm&#x2019;s length borrowings based on
the current financial position of the Company and asserts the carrying value is the best estimate of the Company&#x2019;s legal liability
and represents the fair value for the promissory note. This would be considered a Level 2 input in the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Credit
                                            risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The financial
instrument that potentially subjects the Company to credit risk consists of cash. The Company only has an immaterial cash balance and
is not exposed to significant credit risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Market
                                            risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Market
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate due to changes in market prices. Market
risk comprises two types of risk: interest rate risk and foreign currency risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
                                            rate risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
rate risk consists of two components:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
                                            flow risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To the extent
that payments made or received on the Company&#x2019;s monetary assets and liabilities are affected by changes in the prevailing market
interest rates, the Company is exposed to interest rate cash flow risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
is exposed to interest rate cash flow risk on promissory notes payable of $500,000, which incur a variable interest rate of prime plus
1%. A hypothetical change of 1% on interest rates would increase or decrease net loss and comprehensive loss by $5,000.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 58.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Price
                                            risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To the extent
that changes in prevailing market interest rates differ from the interest rate on the Company&#x2019;s monetary assets and liabilities,
the Company is exposed to price risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company&#x2019;s
promissory notes payable consist of $100,000 of variable interest rate notes and $5,155,334 of fixed interest rate notes. All of these
notes are past due and are currently due on demand while interest continues to accrue. Due to the delinquency of the fixed interest rate
promissory notes payable, there is no active market for these instruments and fluctuations in market interest rates do not have a significant
impact on their estimated fair values as of December&#160;31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At December&#160;31,
2021, the effect on net loss and comprehensive loss of a hypothetical change of 1% in market interest rate cannot be reasonably determined.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
                                            currency risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
incurs certain accounts payable and expenses in Canadian and Singapore dollars and is exposed to fluctuations in changes in exchange
rates between the U.S. and Canadian dollars, as well as U.S. and Singapore dollars. As at December&#160;31, 2021, the effect on net loss
and comprehensive loss of a hypothetical change of 10% between the U.S. and Canadian dollars and between the U.S. and Singapore dollars
would not be material. The Company has not entered into any foreign currency contracts to mitigate risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80B_eus-gaap--IncomeTaxDisclosureTextBlock_zaI5Y2W6KPFi" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_829_zv2oHkNqkF3i"&gt;Income
taxes &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The provision
for income taxes differs from the result that would be obtained by applying the statutory tax rate of 21% (2020&#160;- 21%) to income
(loss) before income taxes. The difference results from the following items:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zvL76V5E9UR8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B3_zgBrAVld289l" style="display: none"&gt;Scheduled of income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20210101__20211231_z4HUb7J5Y5oa" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20200101__20201231_z73kIHqj3at5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iN_di_msITEBz9SR_zQBZWZSbLB1i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Computed expected benefit of income taxes&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,773,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,242,363&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ShareBasedCompensation_maITEBz9SR_zavLZYmCJN8d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;925,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;593,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NondeductibleInterestExpense_iN_pp0p0_di_msITEBz9SR_zwiuBNY9Dqb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Non-deductible interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;334,556&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79,418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ExpiryOfTaxCredits_maITEBz9SR_zcKv2gjUpS0b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expiry of tax credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;773,050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;929,432&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TrueUpOfPriorYearBalances_maITEBz9SR_zdTztmRvqT5c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;True up of prior year balances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;99,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,214,608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_maITEBz9SR_zoXXv7TVAK78" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Increase (decrease) in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(359,307&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,574,980&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBz9SR_zG9SREAfknbh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1372"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zjVXWpesd7U3" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The components
of the net deferred income tax asset, the statutory tax rate and the amount of the valuation allowance are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zNsLvZbBEPNl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B5_zavoDvvYrqva" style="display: none"&gt;Scheduled of net deferred income tax asset&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net operating loss carried forward&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20211231_zJPNIJTOONi8" style="width: 12%; text-align: right" title="Net operating loss carried forward"&gt;35,414,853&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20201231_pp0p0" style="width: 12%; text-align: right" title="Net operating loss carried forward"&gt;37,125,837&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zvLBzsz3QVy4" title="Tax rate"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20200101__20201231_zFYBVIlZTwZ3" title="Tax rate"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Deferred income tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsGross_c20211231_pp0p0" style="text-align: right" title="Deferred income tax assets"&gt;7,437,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredTaxAssetsGross_c20201231_pp0p0" style="text-align: right" title="Deferred income tax assets"&gt;7,796,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20211231_zDPQUeD1InB7" style="border-bottom: Black 1pt solid; text-align: right" title="Valuation allowance"&gt;(7,437,119&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20201231_zucGMiCw53i8" style="border-bottom: Black 1pt solid; text-align: right" title="Valuation allowance"&gt;(7,796,426&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net deferred income tax asset&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20211231_zhq66U8kNJq4" style="border-bottom: Black 1pt solid; text-align: right" title="Net deferred income tax asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsNet_iI_pdp0_c20201231_zWs6mSqNyUN2" style="border-bottom: Black 1pt solid; text-align: right" title="Net deferred income tax asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1395"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zZQnHX1blREj" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The potential
benefit of the deferred income tax asset has not been recognized in these consolidated financial statements since it cannot be assured
that it is more likely than not that such benefit will be utilized in future years. The Company believes that the available objective
evidence creates sufficient uncertainty regarding the realizability of the deferred income tax assets such that a full valuation allowance
has been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The operating
losses amounting to $35,414,000 for utilization in the United States, the jurisdiction where they were incurred, will expire between
2022 and 2041 if they are not used. The following table lists the fiscal year in which the loss was incurred and the expiration date
of the operating loss carryforwards:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_z2SSKzTeluI2" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B0_zU1y0q9M3QY6" style="display: none"&gt;Scheduled of operating loss carryforward&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
    Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Expiry
    Date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_c20211231__us-gaap--TaxPeriodAxis__custom--TaxYear2002Member_pp0p0" style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,504,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2003&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__custom--TaxYear2003Member_zeyV05mNvFFa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,776,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2004&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__custom--TaxYear2004Member_za8VbItwVbR6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,251,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__custom--TaxYear2005Member_zpWOMrtSqo6h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,304,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2006&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2006Member_zx0iLcuJUOIe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,532,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2007&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2007Member_zw16ijeWKt77" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,480,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2008&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2008Member_zkyIdJNYAKG1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2009Member_z6m5ksDPvYOa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,723,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2010&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2010Member_z2nMypaDBpjf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;823,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2011&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2011Member_zWvJ3d0bOpZ3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,747,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2012&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2012Member_z4DmMopZElbd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,638,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2013&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2013Member_zkNw7UN5zS26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,403,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2033&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2014&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2014Member_zDx04ZXHTwi6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,595,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2015Member_znttisowLfsl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,619,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2016&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2016Member_zKPjue1RaGga" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,171,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2036&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2017&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2017Member_z8rDXSwQOJ14" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;928,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2037&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2018Member_z663PZd4jS77" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;720,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2038&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2019Member_zS5braIypkj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,921,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2020Member_zGVrDCGvx5U7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,236,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2021Member_zwApk5mup0Fe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,443,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2041&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231_zG4O42Cu9o9c" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,414,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AB_ze93E1HyJvXi" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zvL76V5E9UR8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B3_zgBrAVld289l" style="display: none"&gt;Scheduled of income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20210101__20211231_z4HUb7J5Y5oa" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20200101__20201231_z73kIHqj3at5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iN_di_msITEBz9SR_zQBZWZSbLB1i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Computed expected benefit of income taxes&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,773,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,242,363&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ShareBasedCompensation_maITEBz9SR_zavLZYmCJN8d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Stock-based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;925,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;593,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NondeductibleInterestExpense_iN_pp0p0_di_msITEBz9SR_zwiuBNY9Dqb3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Non-deductible interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;334,556&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79,418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ExpiryOfTaxCredits_maITEBz9SR_zcKv2gjUpS0b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expiry of tax credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;773,050&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;929,432&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TrueUpOfPriorYearBalances_maITEBz9SR_zdTztmRvqT5c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;True up of prior year balances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;99,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,214,608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pp0p0_maITEBz9SR_zoXXv7TVAK78" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Increase (decrease) in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(359,307&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,574,980&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBz9SR_zG9SREAfknbh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1372"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">1773096</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1242363</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">925449</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">593885</us-gaap:ShareBasedCompensation>
    <ALRT:NondeductibleInterestExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-334556</ALRT:NondeductibleInterestExpense>
    <ALRT:NondeductibleInterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-79418</ALRT:NondeductibleInterestExpense>
    <ALRT:ExpiryOfTaxCredits
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">773050</ALRT:ExpiryOfTaxCredits>
    <ALRT:ExpiryOfTaxCredits
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">929432</ALRT:ExpiryOfTaxCredits>
    <ALRT:TrueUpOfPriorYearBalances
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">99348</ALRT:TrueUpOfPriorYearBalances>
    <ALRT:TrueUpOfPriorYearBalances
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1214608</ALRT:TrueUpOfPriorYearBalances>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-359307</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-1574980</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zNsLvZbBEPNl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income taxes (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B5_zavoDvvYrqva" style="display: none"&gt;Scheduled of net deferred income tax asset&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net operating loss carried forward&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20211231_zJPNIJTOONi8" style="width: 12%; text-align: right" title="Net operating loss carried forward"&gt;35,414,853&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20201231_pp0p0" style="width: 12%; text-align: right" title="Net operating loss carried forward"&gt;37,125,837&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zvLBzsz3QVy4" title="Tax rate"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20200101__20201231_zFYBVIlZTwZ3" title="Tax rate"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Deferred income tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsGross_c20211231_pp0p0" style="text-align: right" title="Deferred income tax assets"&gt;7,437,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredTaxAssetsGross_c20201231_pp0p0" style="text-align: right" title="Deferred income tax assets"&gt;7,796,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20211231_zDPQUeD1InB7" style="border-bottom: Black 1pt solid; text-align: right" title="Valuation allowance"&gt;(7,437,119&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20201231_zucGMiCw53i8" style="border-bottom: Black 1pt solid; text-align: right" title="Valuation allowance"&gt;(7,796,426&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net deferred income tax asset&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20211231_zhq66U8kNJq4" style="border-bottom: Black 1pt solid; text-align: right" title="Net deferred income tax asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsNet_iI_pdp0_c20201231_zWs6mSqNyUN2" style="border-bottom: Black 1pt solid; text-align: right" title="Net deferred income tax asset"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1395"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">35414853</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">37125837</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7437119</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7796426</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">7437119</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7796426</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_z2SSKzTeluI2" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Income taxes (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span id="xdx_8B0_zU1y0q9M3QY6" style="display: none"&gt;Scheduled of operating loss carryforward&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
    Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Expiry
    Date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_c20211231__us-gaap--TaxPeriodAxis__custom--TaxYear2002Member_pp0p0" style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,504,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2003&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__custom--TaxYear2003Member_zeyV05mNvFFa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,776,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2004&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__custom--TaxYear2004Member_za8VbItwVbR6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,251,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__custom--TaxYear2005Member_zpWOMrtSqo6h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,304,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2006&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2006Member_zx0iLcuJUOIe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,532,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2007&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2007Member_zw16ijeWKt77" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,480,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2008&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2008Member_zkyIdJNYAKG1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2009&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2009Member_z6m5ksDPvYOa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,723,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2010&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2010Member_z2nMypaDBpjf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;823,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2011&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2011Member_zWvJ3d0bOpZ3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,747,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2012&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2012Member_z4DmMopZElbd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,638,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2013&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2013Member_zkNw7UN5zS26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,403,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2033&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2014&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2014Member_zDx04ZXHTwi6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,595,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2015Member_znttisowLfsl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,619,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2016&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2016Member_zKPjue1RaGga" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,171,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2036&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2017&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2017Member_z8rDXSwQOJ14" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;928,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2037&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2018Member_z663PZd4jS77" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;720,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2038&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2019Member_zS5braIypkj4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,921,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2039&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2020Member_zGVrDCGvx5U7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,236,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2040&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231__us-gaap--TaxPeriodAxis__us-gaap--TaxYear2021Member_zwApk5mup0Fe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,443,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2041&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_pp0p0_c20211231_zG4O42Cu9o9c" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Opearting Loss Carryforward"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,414,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_custom_TaxYear2002Member"
      decimals="0"
      unitRef="USD">2504000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_custom_TaxYear2003Member"
      decimals="0"
      unitRef="USD">2776000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_custom_TaxYear2004Member"
      decimals="0"
      unitRef="USD">1251000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_custom_TaxYear2005Member"
      decimals="0"
      unitRef="USD">1304000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2006Member"
      decimals="0"
      unitRef="USD">1532000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2007Member"
      decimals="0"
      unitRef="USD">1480000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2008Member"
      decimals="0"
      unitRef="USD">1600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2009Member"
      decimals="0"
      unitRef="USD">1723000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2010Member"
      decimals="0"
      unitRef="USD">823000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2011Member"
      decimals="0"
      unitRef="USD">1747000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2012Member"
      decimals="0"
      unitRef="USD">1638000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2013Member"
      decimals="0"
      unitRef="USD">1403000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2014Member"
      decimals="0"
      unitRef="USD">2595000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2015Member"
      decimals="0"
      unitRef="USD">1619000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2016Member"
      decimals="0"
      unitRef="USD">1171000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2017Member"
      decimals="0"
      unitRef="USD">928000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2018Member"
      decimals="0"
      unitRef="USD">720000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2019Member"
      decimals="0"
      unitRef="USD">3921000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2020Member"
      decimals="0"
      unitRef="USD">2236000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2021-12-31_us-gaap_TaxYear2021Member"
      decimals="0"
      unitRef="USD">2443000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">35414000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zYeLMwbBAk8e" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12. &lt;span id="xdx_826_zXN4jgQovQW5"&gt;Operating segments&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company
has one operating segment, development of diabetes hardware and software. The Company&#x2019;s geographical segments are summarized as
follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zqb7Yj1VfZNc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;&lt;span id="xdx_8B5_zsbfhMd9vA8d" style="display: none"&gt;Schedule of Operating Segments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Current and Total Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;9,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_c20201231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;7,632&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;110,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_c20201231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&#160;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;73,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_c20201231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;101,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Assets_iI_c20211231_zuoNgxeDYed5" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;193,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20201231_zRfyx9uxDPv5" style="border-bottom: Black 1pt solid; text-align: right"&gt;128,849&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1477"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Revenue"&gt;7,468&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1481"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&#160;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1483"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1485"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;7,468&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20200101__20201231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1489"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherMember_zf8z41cYTkQ1" style="text-align: right" title="Net Loss"&gt;(36&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherMember_z9cntkJDAzB9" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1493"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__country--SG_zzVzDCLssMpg" style="text-align: right" title="Net Loss"&gt;(195,308&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--SG_zWRVQFdlEyG3" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1497"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&#160;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zq4JLO0S3m19" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(8,247,971&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zilppdEXZF4" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(5,916,017&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231_zfFZWlnYaTg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(8,443,315&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20200101__20201231_zN8clx0QCAzb" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(5,916,017&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zqb7Yj1VfZNc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;&lt;span id="xdx_8B5_zsbfhMd9vA8d" style="display: none"&gt;Schedule of Operating Segments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Current and Total Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;9,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_c20201231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;7,632&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;110,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_c20201231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&#160;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;73,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_c20201231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;101,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Assets_iI_c20211231_zuoNgxeDYed5" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;193,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Assets_iI_c20201231_zRfyx9uxDPv5" style="border-bottom: Black 1pt solid; text-align: right"&gt;128,849&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1477"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Revenue"&gt;7,468&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1481"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&#160;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20210101__20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1483"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20200101__20201231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1485"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;7,468&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20200101__20201231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1489"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__custom--OtherMember_zf8z41cYTkQ1" style="text-align: right" title="Net Loss"&gt;(36&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__custom--OtherMember_z9cntkJDAzB9" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1493"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__country--SG_zzVzDCLssMpg" style="text-align: right" title="Net Loss"&gt;(195,308&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--SG_zWRVQFdlEyG3" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1497"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&#160;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__country--US_zq4JLO0S3m19" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(8,247,971&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_pp0p0_c20200101__20201231__srt--StatementGeographicalAxis__country--US_zilppdEXZF4" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(5,916,017&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20210101__20211231_zfFZWlnYaTg" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(8,443,315&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_pp0p0_c20200101__20201231_zN8clx0QCAzb" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(5,916,017&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_custom_OtherMember"
      decimals="0"
      unitRef="USD">9547</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_custom_OtherMember"
      decimals="0"
      unitRef="USD">7632</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_country_SG"
      decimals="0"
      unitRef="USD">110527</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_country_SG"
      decimals="0"
      unitRef="USD">20000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_country_US"
      decimals="0"
      unitRef="USD">73143</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-12-31_country_US"
      decimals="0"
      unitRef="USD">101217</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">193217</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">128849</us-gaap:Assets>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-12-31_country_SG"
      decimals="0"
      unitRef="USD">7468</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">7468</us-gaap:Revenues>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_custom_OtherMember"
      decimals="0"
      unitRef="USD">-36</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_country_SG"
      decimals="0"
      unitRef="USD">-195308</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_country_US"
      decimals="0"
      unitRef="USD">-8247971</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_country_US"
      decimals="0"
      unitRef="USD">-5916017</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">-8443315</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-5916017</us-gaap:NetIncomeLoss>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_804_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_z0AVrrfENvVk" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;13. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_825_zgJndtqk4gt4"&gt;Supplemental
information with respect to cash flows&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_znlsYtOO3xoi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Supplemental information with respect to cash flows (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zWAKXlsQZyMb" style="display: none"&gt;Scheduled of cash flows information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20210101__20211231_zPT3ydpEfQm3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20200101__20201231_zcMtsFpqm0l1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--CommonStockIssuedToRetireAccountsPayable_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; padding-left: 5.4pt"&gt;Common stock issued to retire accounts payable&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;194,186&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--CommonStockIssuedToRetireInterestPayable_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Common stock issued to retire interest payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,318,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--CommonStockIssuedToRetirePromissoryNotesPayable_zFLBP8gR80o6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Common stock issued to retire promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1518"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CommonStockIssuedToRetireLineOfCreditPayable_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Common stock issued to retire line of credit payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,681,458&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_znlsYtOO3xoi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Supplemental information with respect to cash flows (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zWAKXlsQZyMb" style="display: none"&gt;Scheduled of cash flows information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20210101__20211231_zPT3ydpEfQm3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20200101__20201231_zcMtsFpqm0l1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt;December 31, &lt;br/&gt;2020&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--CommonStockIssuedToRetireAccountsPayable_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; padding-left: 5.4pt"&gt;Common stock issued to retire accounts payable&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;194,186&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--CommonStockIssuedToRetireInterestPayable_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Common stock issued to retire interest payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,318,542&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--CommonStockIssuedToRetirePromissoryNotesPayable_zFLBP8gR80o6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Common stock issued to retire promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1518"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CommonStockIssuedToRetireLineOfCreditPayable_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Common stock issued to retire line of credit payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;9,681,458&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <ALRT:CommonStockIssuedToRetireAccountsPayable
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">194186</ALRT:CommonStockIssuedToRetireAccountsPayable>
    <ALRT:CommonStockIssuedToRetireAccountsPayable
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">60000</ALRT:CommonStockIssuedToRetireAccountsPayable>
    <ALRT:CommonStockIssuedToRetireInterestPayable
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">3000</ALRT:CommonStockIssuedToRetireInterestPayable>
    <ALRT:CommonStockIssuedToRetireInterestPayable
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2318542</ALRT:CommonStockIssuedToRetireInterestPayable>
    <ALRT:CommonStockIssuedToRetirePromissoryNotesPayable
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="USD">20000</ALRT:CommonStockIssuedToRetirePromissoryNotesPayable>
    <ALRT:CommonStockIssuedToRetireLineOfCreditPayable
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">9681458</ALRT:CommonStockIssuedToRetireLineOfCreditPayable>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zHX8OXWCCzdf" style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82D_zRcEppIOV7Sb"&gt;Subsequent
events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 18, 2022, the Company issued a prospectus whereby it distributed 101,025,592 subscription
                                            rights to its shareholders to purchase shares of common stock of the Company at a price of
                                            $0.05 per share. The rights were set to expire on February 18, 2022, subsequently extended
                                            to March 15, 2022, after which time management has 150 days to allocate the rights to other
                                            parties. On such case-by-case basis, the Company will allow for the exercise of any such
                                            shareholders until April 1, 2022. If fully exercised, this may provide financing of approximately
                                            $5,000,000 to the Company.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On March 18, 2022, the Company extended the commitment letters previously issued to two creditors who are relatives of the Chairman and Chief Executive Officer of the Company offering them an aggregate 20,000,000 shares of common stock in exchange for the extinguishment of $1,541,000 in promissory notes and interest payable (notes 6(b)(v) and 8) from December&#160;31, 2021 to December&#160;31, 2022. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending the vesting period under vesting terms, which have not been met, from September&#160;30, 2021 and December&#160;31, 2021 to December&#160;31, 2022 and from June&#160;30, 2022 to June&#160;30, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On March 18, 2022, the Company modified 2,500,000 options previously granted to an individual on October 4, 2021 by modifying the vesting terms of 1,000,000 options from performance conditions to immediately vesting and cancelling the remaining 1,500,000 options.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035 and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company received an advance from a shareholder for US$200,000 which will mature and be repayable on July 31, 2022. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="margin: 0 0 0 0.5in; text-align: justify"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
